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Abstract
A variety of signaling mechanisms are employed to maintain healthy levels of glucose in the
blood stream. The hormone insulin is one of the primary regulators of glucose homeostasis.
Insulin, which activates glucose uptake, is released from pancreatic β-cells in a bi-phasic
manner. The rst phase is triggered by increased ATP levels in the cell. The second release
phase is triggered by the so-called amplifying pathway [37, 80], which has not been fully
characterized. Recent experimental evidence indicates that pyruvate-recycling pathways
are key components of the amplifying pathway. The fuel intermediates from these pathways
may be the signaling factors that couple insulin-release to glucose availability. The co-factor
nicotinamide adenine dinucleotide phosphate (NADPH) has been identied as a putative
coupling factor. In this work we develop a kinetic model for the tricarboxylic acid cycle
and pyruvate recycling pathways, building on the previous modeling eorts of Westermark
et al. [110]. and Yugi and Tomita [116]. We successfully validated the model against
recent experimental observations. Analysis of the model provides predictions of the ux
distributions in the pyruvate recycling pathways. Moreover, model simulations provides
hypotheses to guide further experimental investigation, and suggest potential drug targets
for treatment of type 2 diabetes.
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Type 2 diabetes is characterized by the functional failure of pancreatic β-cells to regulate
insulin secretion. β-cells function as glucose sensors; they release the hormone insulin
into the blood stream when the glucose level increases above a threshold value. Insulin
promotes glucose uptake in peripheral tissue and suppresses the release of stored lipids
from adipose tissue. In type 2 diabetes, patients develop insulin resistance. That is, the
release of insulin does not activate any cellular response. Another symptom is the failure of
β-cells to synchronize insulin release with changing levels of glucose; insulin release by β-
cells becomes irregular. In the later stages of the disease, both impaired insulin release and
insulin resistance are typically observed. This leads to partial loss of β-cell mass, making
the disease chronic. Type 2 diabetes is predominant in adults, especially those who are
obese and exhibit sedentary behavior. The prevalence of the disease has lead to a major
thrust for the development of drugs to treat type 2 diabetes. An in depth understanding
of the complexity of insulin signaling would be helpful in identifying the candidate drug
1
targets.
The functional failure of β-cells in type 2 diabetes aects these cells ability to properly
regulate insulin secretion when the glucose level is elevated in the blood stream. This
glucose-derived signaling, which is the primary regulator of insulin secretion by β-cells, is
called glucose-stimulated insulin-secretion (GSIS). Any related molecules that are down-
stream products of glucose metabolism are dened as glucose-derived potentiators of insulin
secretion.
The mechanisms by which elevated glucose levels trigger the release of insulin have
not been fully characterized. It has been observed that GSIS is bi-phasic. The initial
release phase involves a sequence of processes known as the KATP-dependent pathway:
increased glucose metabolism increases the ratio of cytosolic adenosine triphosphate (ATP)
to adenosine diphosphate (ADP) causing closure of ATP-dependent potassium (KATP)
channels; depolarization of the cell membrane follows, causing an inux of Ca2+, which
triggers insulin vesicle exocytosis [81, 82]. This rst phase of insulin release, known as
the triggering signal, occurs within ten minutes following glucose stimulation [37, 76].
The second release phase follows after the rst, and is more sustained. It is prompted
by the KATP-independent pathway, also known as the amplifying pathway [37, 80]. The
initial discovery that the two pathways are independent [37] prompted a search for non-
ATP-related metabolic responses to increased glucose availability. A full understanding of
glucose-stimulated insulin-secretion will require characterization of the metabolic signaling
mechanisms responsible for both release phases.
2
Initial studies of the amplifying pathway focused on the metabolism of pyruvate in
the mitochondria. In most cell types, pyruvate feeds the tricarboxylic acid (TCA) cy-
cle via the enzyme pyruvate dehydrogenase (PDH), which generates acetyl-CoA. β-cells
are one of the few cell-types that express signicant quantities of the enzyme pyruvate
carboxylase (PC), which provides an alternative route from pyruvate to the TCA cycle
(producing mitochondrial oxaloacetate (OAA) from pyruvate, see Figure 1.1). In β-cells,
pyruvate ows into mitochondrial pathways through these enzymes in approximately equal
proportion [63, 99, 56, 64, 7, 11, 45]. Pyruvate that enters the TCA cycle via pyruvate
carboxylase can readily be recycled back to pyruvate, either directly from OAA (via PC)
or after further metabolism of OAA in the TCA cycle, possibly involving both metabolic
and cytosolic enzyme activity [65]. The experiments of Lu et al. [63] revealed that GSIS is
related to PC-catalyzed pyruvate recycling, while PDH-catalyzed conversion of pyruvate to
acetyl-coA does not play a signicant role in GSIS. PC-based pyruvate recycling involves
regeneration of pyruvate from TCA cycle intermediates via three distinct pathways (Figure
1.1): the pyruvate/malate cycle, the pyruvate/citrate cycle, and the pyruvate/isocitrate
cycle [66]. Each cycle begins with the conversion of mitochondrial pyruvate to mitochon-
drial oxaloactetate and ends with the conversion of malate to pyruvate by malic enzyme.
(Malic enzyme is active in both the mitochondria and the cytosol; in β-cells, the cytosolic
form carries the vast majority of the pyruvate recycling ux.)
The pyruvate/malate cycle involves conversion of mitochondrial OAA to malate, via
mitochondrial malate dehydrogenase. Mitochondrial malate then follows one of two routes:
it can be directly converted to pyruvate by mitochondrial malic enzyme (MEm), or it can
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be transported to the cytosol via the dicarboxylate carrier (DIC) and then converted back
to pyruvate by cytosolic malic enzyme (MEc).
The pyruvate/citrate cycle also begins with OAA following its normal route through
the TCA cycle: it combines with Acetyl-CoA to form citrate (via citrate synthase (CS)).
This mitochondrial citrate can then be converted to isocitrate by mitochondrial aconitase
(ACOm). Mitochondrial citrate and isocitrate are transported into the cytosol by the
citrate-isocitrate carrier (CIC). The cytosolic form of aconitase (ACOc) can then convert
isocitrate to citrate. Cytosolic citrate lyase (CLc) converts citrate to oxaloacetate (releasing
Acetyl-CoA). This cytosolic OAA can then be converted to malate by the cytosolic form of
malate dehydrogenase (MDHc). Finally malate is converted to pyruvate by malic enzyme,
thus completing the cycle. (This last step is shared with the pyruvate/malate cycle.)
Like the pyruvate/citrate cycle, the pyruvate/isocitrate cycle also starts with oxaloac-
etate being converted to citrate and isocitrate and the subsequent exit of these metabolites
from the mitochondria through the citrate/isocitrate carrier (CIC). In the cytosol, citrate
is converted to isocitrate by ACOc. Isocitrate is then converted to α-ketoglutarate (α-KG)
by cytosolic NADP-dependent isocitrate dehydrogenase enzyme (ICDc). α-KG is then
transported back into the mitochondria by the oxoglutarate carrier (OGC). Once in the
mitochondria, α-KG follows the normal TCA reaction chain to be converted to malate,
which can then be converted back to pyruvate by malic enzyme. (Again, this last step is





































Figure 1.1: Pyruvate recycling pathways and the and amplifying signal for insulin release.
The yellow arrows in the metabolic pathway indicate pyruvate carboxylase and malic en-
zyme, which are shared by all the three pyruvate recycle pathway. The brown arrows are
for pyruvate-malate cycle, green arrows are for pyruvate-citrate cycle, and blue arrows are
for pyruvate-isocitrate cycle. The red arrows shows the alternative possibility of completing
the pyruvate-isocitrate cycle.
In recent years, studies have focused on the identication of metabolic coupling factors
(MCF) which may act as signals in the amplifying pathway. These studies, provide growing
evidence that the pyruvate-recycling pathways generate a metabolic factor that couples in-
creased glucose consumption to insulin release [49, 88, 50, 58, 87]. A number of MCFs have
been proposed, including NADPH, α-ketoglutarate (or its derivatives), and guanosine-5'-
triphosphate (GTP) (generated by the succinylCoA dehydrogenase (SCS) [66, 76]. Recent
observations suggest that NADPH is a key signaling molecule [88, 65]. NADPH is a byprod-
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uct of all of the pyruvate recycling pathways [64]; it is generated by malic enzyme (a step
shared by all three cycles), and, in the pyruvate/isocitrate pathway, by isocitrate dehy-
drogenase; this enzyme has recently received signicant attention because its silencing was
found to aect GSIS [88].
When addressing a complex metabolic network like the TCA cycle, it can be dicult to
predict the eects of individual genetic or biochemical perturbations on the entire system.
Kinetic modeling provides a framework for addressing the network in a systematic and
quantitative manner. Furthermore, kinetic modeling provides a mathematical framework
for analysis of temporal, genotypic and phenotypic changes associated with the metabolic
pathway. Analysis of kinetic models aids in the interpretation of experimental data and
can help in designing further experiments to elucidate the underlying biological process.
A number of computational models have been developed to describe aspects of the TCA
cycle and GSIS. Westermark et al. [110] developed a model of mitochondrial nicotinamide
adenine dinucleotide (NADH) shuttling (involving 10 metabolites and 19 enzymatic reac-
tions). They validated the model against the ndings of Eto et al. [23] which characterize
the NADH shuttle in β-cells. The TCA cycle has been the subject of many modeling
studies. A detail model of mitochondrial metabolism was recently developed by Yugi and
Tomita [116]. Their model describes 58 enzymatic reactions involving 117 metabolites, and
incorporates four pathways: the respiratory chain, the TCA cycle, fatty acid β oxidation,
and the inner membrane transport system. Jiang et al [47] developed a detailed model of
GSIS that describes 44 enzymatic reactions and 59 metabolic state variables. Their model
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describes ve metabolic pathways: glycolysis, the TCA cycle, the respiratory chain, NADH
shuttling, and the pyruvate cycle. While these studies involve validation against a range of
experimental ndings, a systematic corroboration with experimental results on pyruvate
recycling has not been attempted.
In this study, we build on these previous eorts by developing a mathematical model
of β-cell metabolism that describes pyruvate recycling. Our model describes the TCA cy-
cle, the pyruvate/malate shuttle, the pyruvate/citrate shuttle, and the pyruvate/isocitrate
shuttle, as shown in Figure 1.1. The model describes 24 metabolites involved in 30 enzy-
matic reactions; it draws elements from the models of Yugi and Tomita [116], Westermark
et al. [110] and Sweet and Matschinsky [108]. The model involves 123 parameters; 89 were
taken directly from the literature, 34 were calibrated by tting to the experimental obser-
vations of Ronnebaum et al. [88]. We tested the model's accuracy by comparing model
predictions to qualitative and quantitative observations of system behavior as reported in
the literature on β-cell metabolism [49, 50, 63, 45]. Once we had conrmed the validity
of the model, we carried out local and global sensitivity analysis to identify the important
control points in the pyruvate recycling pathways. The analysis reveals that the Vmax
values of dicarboxylate carrier (DIC), pyruvate carboxylase (PC), pyruvate dehydrogenase
(PDH), cytosolic malic enzyme cytosolic (MEc), pyruvate transporter (PYC) and citrate
synthase (CSm) are important control points in the pathway.
7
Chapter 2
Biology of Pyruvate Recycling Pathways
Chapter Outline In this chapter we describe the basic physiology associated with pan-
creatic β-cells and experiments related to β-cells metabolism. We rst summarize the
basic physiology of pancreatic β-cells. Next, we report the ndings which lead to the
conclusion that insulin is released into the blood stream in a bi-phasic manner, by the
triggering and amplifying pathways. Then, we illustrate the 13C-isotopomer-based ux-
quantication analysis that established the correlation between glucose stimulated insulin
secretion (GSIS) and pyruvate recycling ux. Finally, we will summarize the series of
gene knock-down experiments of enzymes associated with pyruvate recycling. Finally, we
discuss plausible metabolic coupling factors.
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2.1 Introduction to β-Cell Physiology
Pancreatic β-cells Pancreatic β-cells are found in the Islet of Langerhans. Pancreatic
β-cells constitutes 75-85% of the Islet of Langerhans. Pancreatic β-cells are the place where
insulin is expressed and released into blood stream. The signaling mechanism of insulin re-
lease into the blood stream is a well regulated and controlled mechanism which is inuenced
by many factors. In recent years research has indicated that fuel intermediates stimulate
insulin secretion primarily by co-ordination of their metabolism in the mitochondria and
cytoplasm of β-cells [76, 82, 66].
Mitochondria Most eukaryotic cells contain many mitochondria, which occupy up to
25 percent of the volume of the cytoplasm. Mitochondria are among the largest organelles,
generally exceeded in size only by the nucleus, (and by the plant organelles  vacuoles,
and chloroplasts). Mitochondria contain two very dierent membranes, an outer one and
an inner one, separated by the inter-membrane space (Figure 2.1). The outer membrane,
composed of about half lipid and half protein, contains proteins that render the membrane
permeable to molecules having molecular weights as high as 10,000 a.m.u. The inner mem-
brane, which is much less permeable, is about 20 percent lipid and 80 percent protein.
The surface area of the inner membrane is greatly increased by a large number of infold-
ings, or cristae, that protrude into the matrix, or central space. In eukaryotic cells, the
mitochondrion is the place where ATP is generated through the degradation of glucose
and fatty acids. Aerobic metabolism of glucose and fatty acids generates ATP and other





Figure 2.1: Schematic diagram of mitochondria.
tory processes. In the pancreatic β-cell, glucose and its intermediates are channeled to
the mitochondria, where signals for the initiation and potentiation of insulin secretion are
generated [88, 51]. Normal mitochondrial activity appears to be equally important in the
action of insulin on its target tissues [66]. Insulin resistance in the elderly and in relatives
of type 2 diabetic patients have also been associated with mitochondrial dysfunction [111].
Figure 2.2: Structure





Insulin Insulin is a peptide hormone and is expressed in
pancreatic β-cells (Figure 2.2). The synthesis of insulin be-
gins at the translation of the insulin gene, which resides on
chromosome 11. During translation, two introns are spliced
out of the mRNA product, which encodes a protein of 110
amino acids in length. This primary translation product is
called proinsulin and is inactive. It contains a signal peptide
of 24 amino acids in length, which is required for the peptide
to cross the cell membrane. After a series of modications
in the endoplasmic reticulum and Golgi apparatus it becomes
active insulin.
Exocytosis (the process through which cells release
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molecules into the outside environment) of the insulin granules (insulin is stored in β-
cells in the form of small clusters, called granules) is triggered by the entry of glucose
into the β-cells. The rise in blood glucose following a meal is detected by the pancreatic
β-cells, which respond by releasing insulin. The secretion of insulin has a broad impact on
metabolism. The eects of insulin are reected in an increase in gene transcription, and
enzyme synthesis during its activity period.
Type 2 Diabetes Diabetes mellitus is the physiological state in which glucose home-
ostasis in the blood stream malfunctions. In the healthy condition, when the amount of
glucose increases in the blood (e.g after a meal), the hormone insulin is released from the
pancreas into the blood stream. This initiates a sequence of cellular events: insulin ac-
tivates muscle and fat cells to remove glucose from the blood, and activates the liver to
metabolize glucose, thus regulating glucose homeostasis in the blood.
In diabetic patients, the blood glucose level remains high, due to the failure of glucose
homeostasis. One reason for this malfunction is the mis-regulation of insulin secretion into
the blood stream. Moreover, there are multiple reasons why insulin might not carry out
its action: insulin might not be properly produced in the β-cells, or may not be properly
secreted into the blood stream. This situation leads to dierent types of diabetes classied
according to the type of failure. The two most predominant types of diabetes are type
1 diabetes (5% of cases), which is an autoimmune disorder, and type 2 diabetes (95% of
cases), which is associated with the failure of the insulin signaling mechanism (and is linked
to obesity). Type 1 diabetes mainly aects children. In contrast, type 2 diabetes mostly
aects adults. There is a high correlation between the life style of a person (e.g. obesity)
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and type 2 diabetes. Other forms of diabetes are uncommon, such as gestational diabetes
that occurs during pregnancy, or diabetes caused by a single gene mutation.
There are several factors underlying the malfunction of glucose homeostasis in type 2
diabetes. Two important factors are the body's resistance to insulin (i.e. the failure of cells
to respond properly to insulin) and decient production of insulin by the β-cells. In type
2 diabetes, one can suer from a combination of decient secretion and decient action of
insulin. The decient secretion of insulin might be due to a failure of the glucose stimulated
insulin secretion (GSIS) pathway in β-cells.
2.2 Glucose Stimulated Insulin Secretion
Insulin resistance can manifest out of many factors in type 2 diabetes. Studies done in
animal models and humans suggest that the initializing factor is β-cell failure, which in-
volves a reduction in β-cell mass and malfunctioning of important β-cell functions such
as glucose stimulated insulin secretion (GSIS). β-cells ensure regulation of insulin by re-
sponding to multiple factors, including metabolites (glucose and other nutrients), neural
signals, hormones, and sometimes pharmacological agents. The study of stimulated insulin
secretion led to three important discoveries. First, glucose must be metabolized by β-cells
to induce insulin secretion. The supporting evidence for this conclusion was found when
glucose metabolism was interfered with in the cells. This led to failure of insulin release,
which was restored only by the addition of external metabolized sugars [13, 29]. Second,
Ca2+ is a signicant regulator of insulin secretion. This was established by the fact that
in the absence of Ca2+, glucose failed to initiate insulin secretion [28, 72]. Third, β-cells
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can be excited electrically [16].
In the present work we focus on the glucose-initiated signal, which is bi-phasic. That
is, insulin released in two phases [26, 115]. The rst phase is triggered by the so-called
triggering pathway and the second, more sustained, phase is initiated by the so-called
amplifying pathway. Next, we review the bi-phasic release of insulin secretion in response
to increases in glucose concentration.
Before we start our discussion on bi-phasic release of insulin initiated by glucose metabolism,
we emphasize that there are many other potentiators of insulin secretion which do not
involve glucose mediation (Figure 2.3). Signicant among non-glucose potentiators are in-
cretin hormones glucagon-like peptide-1 (GLP1) and gastrointestinal inhibitory polypep-
tide (GIP), which are released by the enteroendocrine cells of the small and large intestine
(L cells) during the process of food digestion [3]. These hormones trigger the activity of
adenylate cyclase and cyclic AMP in the β-cell. It is signicant to note that GLP1 mod-
ulates the activity of the three ion channels in the β-cell: the KATP channels, the voltage
gated Ca2+ channels and voltage dependent K+ (Kv channels). Kv also plays an important
role in the triggering pathway of GSIS. Finally, there is evidence in support of the amino
acids arginine and leucine as insulin potentiators. Arginine modulates the K+ channels
whereas leucine is known to be an allosteric modier of important enzymes (like glutamate
dehydrogenase) which may have a role in generating potentiators [20, 105]. A schematic
gure of this complex insulin signaling network is provided in Figure 2.3.
The Triggering Pathway Glucose metabolism in β-cells contributes to the tight regula-























Figure 2.3: Schematic of insulin secretion phases and potentiators.
roles in insulin signaling (Figure 2.4).
As the glucose concentration rises, β-cell metabolism increases, generating more ATP.
Consequently, ATP-sensitive K+ channels (KATP channels) close, which results in the mod-
ulation of the K+ conductance. This results in membrane depolarization (charge reversal
across the plasma membrane). One of the primary physiological regulators of these channels
which is derived from glucose is the ATP:ADP ratio, however there may be other regu-
lators. Once a threshold value of membrane depolarization is reached, voltage-operated
Ca2+ channels are activated. These channels open, allowing an inux of Ca2+ into the
β-cell (down the electrical gradient). This opening of Ca2+ channels occurs at regular
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intervals, which oscillate together with membrane potential. This results in oscillation of
Ca2+, which in turn triggers insulin secretion.
The signicant role of KATP channels is demonstrated through agents that open or close
channels without interfering with glucose metabolism. It has been shown that when mouse
islets are stimulated with 15 mmol/g glucose, β-cells display typical electrical activity:
Ca2+ oscillates and insulin secretion is stimulated. However, the opening of K+ channels
with diazoxide causes membrane re-polarization, which results in lowering of Ca2+ and
subsequent inhibition of insulin secretion. Moreover, addition of tolbutamide, which closes
the channels, restores the depolarization and resumption of electrical activity. This results
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Figure 2.4: Schematic illustration of glucose initiated triggering pathway of insulin secre-
tion.
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In summary the GSIS mediated trigger signal follows the following steps:
 Glucose enters the β-cells through facilitated diusion.
 Glucose is metabolized through oxidative metabolism which increases the ATP:ADP
ratio. The increase in this ratio initiates the closure of K+ channels.
 Voltage operated Ca2+ channels are opened.
 Ca2+ inux increases.
 As a result plasma membrane depolarization happens and there is subsequent acti-
vation of the exocytotic mechanisms.
The Amplifying Pathway Evidence for a second phase of insulin secretion emerged in
two independent experiments by Gembal et al. and Sato et al. [26, 94]. This second phase
of activity is initiated by the so-called amplifying pathway.
Glucose stimulated insulin secretion occurs by membrane depolarization mediated by
KATP channels. The activity of KATP channels can be modulated by diazoxide, which
opens the channel without interfering with the insulin secretion process. By adding extra
K+, membrane depolarization can be initiated, which subsequently initiates the insulin
secretion. However, when the function of KATP channels was removed through diazoxide,
glucose was still able to increase insulin secretion where the cells depolarized by KCl [26, 94].
Moreover, experiments were carried out using sulfonylureas, which closes the KATP channels
instead of opening. When the activity of KATP channels is inhibited by sulfonylureas,
glucose was still able to increase insulin secretion. Both these results suggest that there
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is a mechanism through which glucose potentiates insulin secretion that is independent of
KATP channel regulation. This pathway is termed the amplifying pathway. Subsequently,
K+-induced depolarization in the presence of diazoxide was used to show that glucose can
increase insulin secretion independently of KATP channels in rodent islets [55, 25, 48, 10, 70],
human islets [107], perfused rat pancreas [1], and insulin secreting cell lines [41].
Hierarchy between the triggering and amplifying pathways Its has been shown
that the two pathways trigger insulin secretion in a xed order: the amplifying pathway
follows the triggering pathway. The manipulation of KATP channels by diazoxide at low
concentration of glucose showed that the amplifying pathway tends to amplify the trigger
signal [37].
The glucose-derived second messenger that signals the amplifying pathway has not been
conclusively identied; it is the subject of current studies. In the subsequent discussion we
summarize recent evidence that has emerged about the second messenger.
2.3 NMR Experiments
In this subsection we summarize the rat INS-1 derived cell lines that are used to study
the metabolic pathways of β-cells. Then we describe the 13C-isotopomer analysis of these
cell lines that showed that pyruvate recycling through the enzyme pyruvate carboxylase
enzyme (and not through pyruvate dehydrogenase) is correlated with GSIS.
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INS-1 derived cell lines In order to gain better understanding of the biochemical reg-
ulation involved in insulin secretion, Hohmeier et al. [41] derived robust ATP-sensitive K+
channel-dependent and independent cell lines from rat INS-1 cell lines, as follows. First,
rat INS-1 cell lines were transfected by plasmids containing the human proinsulin gene.
Subsequently, three kinds of cell lines were developed based on the glucose-derived insulin-
secretion response: responsive cell lines, moderately responsive cell lines, and less respon-
sive cell lines. The analysis of strongly responsive cell lines was carried out. These cell
lines showed stable glucose response for longer period of time (approximately 7.5 months)
and successful secretion of insulin in response to potentiators like isobutyl-methylxanthine,
and oleate/palmitate. Studies of the KATP channels were carried out using the pharmaco-
logical agents diazoxide, to inhibit the insulin secretion, and sulfonylurea, to potentiated
glucose-induced insulin secretion. These validating the cell lines against the prevailing
hypothesis about the role of the KATP channels. Next, comparison between the poorly re-
sponsive cell lines and the responsive cell lines revealed that the responsive cell lines were
able to increase the insulin secretion in the KATP channel independent manner whereas for
poorly responsive cell lines the insulin secretion was almost identical for both dependent
and independent cases. This validated the presence of the amplifying pathway.
13C-NMR analysis of INS-1 derived cell lines Lu et al. [63] used 13C-NMR istopomer
analysis of glutamate to show that pyruvate recycling is correlated with the GSIS. The
study was carried out in four clonal cell lines: two highly glucose-responsive cell lines (num-
bered 832/13 and 834/40), and two less glucose-responsive cell lines (832/1 and 832/4).
The response characteristics of these cell lines is robust for long periods of tissue culture
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which allowed eective 13C istopomer analysis. Here we summarize the important aspect
of the 13C isotopomer model. In all the subsequent discussion the following denition of
the pyruvate recycling ratio will be used:
Pyruvate Recycling Ratio =
Pyruvate Carboxylase Flux
TCA cycle ux
The 13C istopomer analysis starts by incubating cell lines in the [U-13C6]glucose, iso-
lation of glutamate and nally analysis of 13C istopomer using 13C-NMR spectroscopy.
The spectra was generated for two dierent models (Figure 2.5): pyruvate dehydroge-
nase (PDH) catalyzed conversion of [U-13C3]pyruvate to [U-
13C2]acetyl-CoA and pyruvate
carboxylase catalyzed (PC) conversion of [U-13C3]pyruvate to [1,2,3-
13C3]oxaloacetae (con-
version of pyruvate to [U-13C3]lactate via lactate dehydrogenase (LDH) is common for both
the models). For these two models the glutamate carbon spectra (C2, C4 carbon positions)
will show distinct peaks. If [U-13C3]pyruvate is converted only to [U-
13C2]acetyl-CoA then
the peaks in the spectra of glutamate will show uniformity. However, for the second model
there will be dierent levels of peaks in the (C2, C4 carbon positions) NMR spectra.
The NMR spectra revealed larger peaks in the C4 component glutamate in the respon-
sive cell lines compared to the less responsive cell lines. This is possible only if pyruvate
is derived from TCA cycle intermediates. Signicantly, acetyl-CoA showed a similar trend
of percentage increase in concentration in all the four cell lines as the glucose concentra-
tion was raised (approximately ≈40, ≈70, and ≈85% at 3, 6, and 12 mM glucose level).
Therefore, it can be concluded that PDH-catalyzed conversion of pyruvate to acetyl-CoA














Figure 2.5: Schematic illustration of two models of 13C istopomer analysis of pyruvate
recycling rate.
ratio was measured in the two glucose-responsive cell lines and two unresponsive cell lines.
The results were consistent with the hypothesis that the ratio was increased signicantly
in the two responsive cell lines when glucose concentration was increased from 3 to 12 mM
concentration. In contrast, less responsive lines did not show any signicant rise in the
pyruvate recycling ratio when the glucose concentration was increased. The dose response
curve of the pyruvate recycling ratio showed a linear relationship with insulin release. This
further conrmed the involvement of pyruvate recycling in insulin secretion.
Finally, the activation and inhibition of pyruvate recycling were studied. Glucose-
responsive cell lines were treated with DMM, which is an analogue of malate and so is
expected to increase the conversion of TCA intermediates to pyruvate. The isotopomer
analysis revealed that DMM increased pyruvate recycling by 40%. Further, insulin secretion
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nearly doubled at 12mM glucose. This established a further correlation between pyruvate
recycling and insulin secretion. Next, these cell lines were treated with PAA, which is an
inhibitor of PC. The result was inhibition of insulin secretion at 12mM glucose, conrming
that PC is important for GSIS.
Having conrmed that pyruvate recycling is linked to insulin secretion, studies turned
to the identication of important target points in the pyruvate recycling pathway and
possible metabolic coupling factors (MCF).
2.4 siRNA Gene Knock Down
Recent studies related to β-cell metabolism have focused on identifying control points
and MCFs in the recycling pathway using short interfering RNA (siRNA) mediated gene
silencing technique. siRNA is a double stranded RNA molecule approximately 20-25 base
pairs in length. One of the important roles of siRNA is in RNA interference (RNAi). RNAi
is a process of targeted gene silencing at the mRNA level.
The gene silencing mechanism is initiated by the RNAse enzyme called Dicer, which
breaks down double stranded RNA (dsRNA) into siRNA. In the next step, these siRNAs are
incorporated into a silencing complex called the RNA-induced silencing complex (RISC).
RISC functions to identify complementary messenger RNA (mRNA) and subsequently
inhibit its expression. The process is illustrated in the Figure 2.6.
siRNAs are easily available and have very high eciency of delivery inside cells, which













Figure 2.6: Schematic illustration of siRNA mediated gene silencing. In the rst step the
RNase-III-like enzyme Dicer processes the long dsRNA and miRNA into siRNA/miRNA
duplexes. Next, these siRNAs are assembled into a complex called RISC, which carries out
RNA cleavage (and possibly other modications).
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2.5 Gene Knockdown of Pyruvate Recycling Pathways
The 13C-NMR based isotopomer analysis revealed the role of pyruvate carboxylase (PC)
in pyruvate recycling and established correlation between pyruvate recycling and GSIS.
However, these studies do not identify the specic control points in the pathway that
contribute to insulin release. To gain this understanding, a series of studies were done using
siRNA-mediated gene silencing of enzymes involved in pyruvate recycle. In this section we
describe the important insights developed through these knock-down experiments.
A note on the terminology about experiments: all the comparisons considered below
are drawn between two cell lines: control cell lines and knock-down cell lines. The control
cell lines are transfected with random siRNA and thus there is no genetic manipulation
in these cell lines. Therefore these cell lines can be considered as the wild-type case.
The experimental cell lines involve transfection with complementary siRNA to silence the
corresponding gene; this is the knock-down case.
Isocitrate Dehydrogenase (ICDc) Ronnebaum et al. [88] studied the role of ICDc in
GSIS using siRNA gene silencing experiments in glucose responsive rat insulinoma (INS-
1-derived) cell lines and in primary rat islets. There are three isoforms of ICD which
are expressed in pancreatic β cells. First, is the TCA cycle (mitochondrial) β-cells NAD-
dependent ICD (EC 1.1.1.41). The other two enzymes are NADP dependent (EC 1.1.1.42)
(ICDc). These NADP-dependent enzymes are expressed predominantly in the cytosol
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where they participate in pyruvate recycling. The reaction catalysed by ICDc is :
ICIT (cytosolic) +NADP 
 α-KG (cytosolic) +NADPH
The injection of complementary siRNA targeting ICDc in the cell lines led to a 39±%
decrease in ICDc activity, whereas the mitochondrial isoform was unaected. To study the
ICDc-silencing eect on non-fuel mediated insulin release, cells where stimulated with a
membrane depolarizing concentration of K+. The stimulation resulted in approximately
3-fold increase in insulin secretion (at 2.8mM glucose) in both control cell lines and ICDc-
silenced cell lines. This result indicates that ICDc suppression does not aect the fuel-
independent release of insulin. However, the knock-down of ICDc caused inhibition in
GSIS and reduced glucose-induced pyruvate recycling.
After establishing the validity of silencing the enzyme, its eect on metabolism was stud-
ied. The authors showed that when the glucose concentration was increased, there is a cor-
responding increase in insulin secretion and the NADPH:NADP ratio, thereby establishing
a correlation between GSIS and the NADPH:NADP ratio. Furthermore, ICDc suppression
aected the NADPH concentration. The experiments showed that the NADPH:NADP
ratio increases by approximately 3-fold when glucose is increased from 3mM to 12mM in
control cell lines. Signicantly this ratio did not show the same increase for the ICDc
knock-down case. Next, a small decrease in total concentration NADPH was observed
at high glucose compared to low glucose, both in the control and silenced cell lines, but
overall less concentration was observed in the ICDc-silenced cell lines. This implies that
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the ICDc knock-down aects NADPH at both low glucose and high glucose. Also, the
glycolytic rate was unaected by the ICDc knock-down, but measurement of the pyruvate
recycling using 13C-NMR isotopomer analysis revealed a decrease in the pyruvate recycling
ratio. Finally, the eect of ICDc silencing on dierent TCA cycle intermediate was stud-
ied. The concentration of seven TCA cycle metabolite (pyruvate, citrate, α-KG, succinate,
fumarate, malate, lactate) was measured. Comparisons between the control and silenced
cell lines at 3mM and 12mM glucose were carried out. There was no signicant variation
in the levels of pyruvate, malate, citrate, succinate and fumarate in control and silenced
cell lines. However, lactate levels were increased by 2.8 fold at 12mM glucose concentration
in silenced cell lines compared to control cell lines, whereas α-KG was decreased. Also,
citrate levels were elevated at 3mM glucose in silenced cell lines compared to the control
case. Putting all the information together, these experiments suggest that ICDc has a
signicant role to play in GSIS.
citrate isocitrate carrier (CIC) Joseph et al. [51] studied the role of mitochondrial
CIC in regulation of GSIS. CIC is a transport enzyme that reversibly transports mitochon-
drial citrate (or mitochondrial isocitrate) to the cytosol in exchange for cytosolic malate:
CIT (cytosolic) +MAL (mitochondrial) 
 CIT (mitochondrial) +MAL (cytosolic)
This study was carried out in the INS-1 derived 832/13 cells and primary rat islets. The
inhibition of CIC was carried out by the substrate analogue 1,2,3-benzenetricarboxylate
(BTC) and CIC-specic siRNA (Ad-siCIC). Inhibition by BTC in INS-1 derived 832/13
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cells and primary rat islets resulted in signicant reduction in the both phases (triggering
and amplifying) of insulin secretion, thereby establishing the role of CIC in regulation of
GSIS. Next, the eect of genetic manipulation using Ad-siCIC was studied. Transfection
with Ad-siCIC resulted in 53±8% reduction in CIC protein level. The silencing of CIC
did not aected the glycolytic rate nor the nutrient-independent release of insulin. The
cytosolic citrate level was reduced by 54±2% in Ad- siCIC treated cells (in comparison
to control cells). Also, the total cellular concentration of citrate in the knock-down case
was reduced by 37±3%, while the mitochondrial citrate was unaected (again, compared
to the control case). Furthermore, silencing of CIC resulted in a signicant decrease in
NADPH:NADP ratio compared to control cell lines. CIC is an important participant in
the pyruvate recycle pathway, as it is one of the co-transporters of isocitrate, which is a
substrate of ICDc enzyme, which is know to have signicant role in GSIS. The results
conrmed that CIC has an important role to play in GSIS.
citrate lyase (CL) Joseph et al. [52] investigated the roles of citrate lyase enzyme (CL)
and fatty acid synthase (FAS) in GSIS. Citrate lyase converts cytosolic citrate into cytosolic
oxaloacetate with cytosolic acetyl-CoA as a by-product.
CIT (cytosolic)+CoA (cytosolic) 
 OAA (cytosolic)+Acetyl-CoA (cytosolic)
FAS catalyzes conversion of acetyl-CoA and malonyl-CoA into long-chain fatty acids with
NADPH as one of the co-factors. This series of reaction steps is believed to be one of
the potential generators of metabolic coupling factor (MCF) for GSIS. To investigate the
26
role of these two enzymes siRNA-mediated gene silencing was carried out in INS-1 derived
832/13 cells and primary rat islets.
First we describe the ndings reached by silencing CL. Two complementary siRNA
were built for CL silencing: Ad-siCL2 and Ad-siCL3. Treatment with Ad-siCL2 resulted in
92±6% reduction in mRNA of CL and resulted in 75±4% reduction in CL protein compared
with a control cell lines. Neither of these silencing treatments aected GSIS compared to
control cell lines. The CL silencing reduced the cytosolic oxaloacetae by 54±7% , inhibited
the glucose incorporation into lipid by 43±4% and reduced malonyl-CoA by 83±4%. All
these ndings are expected outcomes of CL suppression.
Next, complementary siRNA for FAS Ad-siFAS was generated. The treatment of Ad-
siFAS in the cell lines reduced the FAS mRNA by 81±2% . Furthermore glucose incorpo-
ration into lipid was reduced by 59±4% with respect to control cell lines. Interestingly this
reduction did not aect GSIS. Similarly, treatment of cell lines by Ad-siCL3 and Ad-siFAS
reduced the mRNA level of CL by 65±4% and FAS mRNA by 52±3% but did not aect
GSIS. Putting the results together it can be concluded that CL and FAS are not required
for GSIS.
Malic Enzyme Ronnebaum et al. [89] studied the eects of silencing the cytosolic
NADP-dependent Malic enzyme (MEc) and the mitochondrial NADH-dependent malic
enzyme (MEm), in INS-1 derived 832/13 cell lines and primary rat insulinoma cells. MEc
catalyzes the conversion of cytosolic malate to cytosolic pyruvate with NADPH is one of the
co-factors, whereas MEm catalyzes the same conversion for mitochondrial species but with
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NADH as co-factor. Together these two enzymes are part of pyruvate-malate pathway.
MAL (mitochondrial) + NAD (mitochondrial) 
 PYR (mitochondrial)+ NADH (mitochondrial)
MAL (cytosolic) + NADP (cytosolic) 
 PYR (cytosolic) + NADPH (cytosolic)
First the cells were treated with two siRNA complementary to MEm: Ad-siMEm1
and Ad-siMEm2. The treatment of cells with Ad-siMEm1 lead to reduction of mRNA by
46±5% while Ad-siME2 decreased the mRNA by 87±1%. The control cell lines showed
5.7±1% fold increase in the insulin release when glucose concentration was increased from
2.5mM (basal) to 12mM (stimulatory). However, the AdsiMEm1 and Ad-siMEm2 treated
cells exhibited only 3.5±0.7% and 2.6±0.5% fold increases respectively: a signicant reduc-
tion. This result may be confounded by the fact MEm suppression aects β-cells growth;
signicant GSIS in INS-1 cell lines requires conuent cell cultures. Furthermore, silencing
of MEm in rat insulinoma cell lines had no eect on the GSIS.
Next the knock-down experiments of MEc was studied. The silencing of MEc in 832/13
cell lines lead to 76±7% decrease in MEc mRNA. In control cell lines the insulin release
showed 6.1±1.2% fold increase from basal to stimulatory glucose concentration, while in
silenced cell lines a 3.3±1% fold increase was observed: a signicant decrease. Furthermore
in rat insulinoma cell lines MEc silencing lead to 82±3% reduction in MEc mRNA, but
did not aect insulin release. Suppression of MEc did not aect the cell growth in 832/13
cell lines nor did it aect the TCA cycle metabolite concentrations. However, silencing did
aect the NADPH concentration. Furthermore, MEc silencing did not aect the pyruvate
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recycling rate. These results show that the pyruvate-malate cycle might not be playing an
important role in GSIS.
Pyruvate Carboxylase (PC) Jensen et al. [46] investigated the eect of silencing
pyruvate carboxylase (PC) on GSIS. PC catalyzes the conversion of pyruvate to oxaloac-
etate.
PYR (mitochondrial) + ATP (mitochondrial) + CO2 (mitochondrial) 

OAA (mitochondrial) + ADP (mitochondrial) + Pi (mitochondrial)
This is an alternative pathway of pyruvate entry into the TCA cycle. The standard
pathway involves pyruvate dehydrogenase catalyzing the conversion of pyruvate to acetyl-
CoA. PC activity is very high in β-cells compared to other cells; in β-cells PC carries
roughly half of the pyruvate ux. It has been shown that the PC-catalyzed reaction is
correlated with GSIS, but the PDH-catalyzed reaction is not [63].
The siRNA gene silencing experiments were carried out in INS-1 derived 832/13 cell
lines and primary rat islets. A complementary Ad-siPC siRNA was constructed to silence
the PC gene. The treatment of the 832/13 cell by Ad-siPC led to an 83% reduction in
mRNA and a 64% decrease in PC protein level. Similarly, transfection of primary rat
islet led to 56% and 35% reduction in PC mRNA and protein level respectively. The Ad-
siPC treatment of the 832/13 cell lines did not aect the glycolytic or glucose oxidation
rates. Interestingly the Ad-siPC treatment did not aect the pyruvate levels either at basal
(2.5mM) or stimulatory (12mM) glucose levels. However, there was an approximately 60%
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increase in the lactate level at 12mM glucose concentration compared to control cell lines.
13C-NMR istopomer analysis revealed that, in Ad-siPC cells, there was no eect on the
pyruvate recycling ratio when glucose is raised from basal to stimulatory level. Since,
the pyruvate level is unchanged due to Ad-siPC treatment there might be two possibilities:
either the activity of the remaining PC enzyme is proportionally increased or PDH activity
has gone up. It is known that acetyl-CoA is an allosteric activator of the PC enzyme.
To analyze the allosteric eect of acetyl-CoA on PC acetyl carnitine level was measured
using quantitative MS/MS technique. acetyl-carnitine is in equilibrium with acetyl-CoA.
Interestingly the acetly-carnitine concentration went up in the Ad-siPC treated cell lines.
This explains the mechanism through which PC specic activity might increase, since PDH
generates acetyl-CoA, while PC does not.
Next the eect on dierent metabolites was studied in Ad-siPC cells with respect to
control cell lines. The silencing of PC did not eect the NADPH:NADP ratio. Furthermore,
PC silencing did not eect the glucose oxidation rate, but there was an approximately
36% decrease in the ATP level in Ad-siPC-treated cells. Finally, the eect on the TCA
cycle intermediate was studied. Compared to control cell lines, only α-KG was decreased
in the knock-down case, when glucose is raised from 2.5mM to 12m. Other TCA cycle
intermediates (succinate, fumarate and malate) were unaected. Therefore, it seems that
β-cells are fairly robust to genetic perturbations in PC.
ARNT Pillai et al. [85] investigated the role of the transcription factor Aryl hydrocarbon
nuclear receptor nuclear translocator (ARNT)/hypoxia-inducible factor(HIF)-1β. To carry
out silencing of ARNT/HIF-1β in INS derived 832/13 cell lines, two complementary siRNA
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were constructed: siARNT1 and siARNT2. The treatment of 832/13 with siARNT1 re-
sulted in 78±4% reduction in ARNT/HIF-1β mRNA while siARNT2 resulted in 56±5%
reduction of mRNA. To measure the eect on insulin release, the comparison between
control cell lines (siControl) and cell lines treated with siARNT1 and siARNT2 was done
at basal (2mM) and stimulatory (16.7mM) glucose concentration. siARNT1 treated lines
showed a 60±10% reduction in insulin release at stimulatory glucose concentration with
respect to siControl cells. Similarly, siARNT2 treatment resulted in 52±17% decrease.
Glycolytic ux was unaected at basal glucose level in siARNT1 transfected cells, but
showed 31±6% reduction at stimulatory glucose level with respect to siControl. However,
there was no signicant change in glucose oxidation both at basal and stimulatory glucose
concentration. The immediate consequence of this is that a glucose induced change in the
ATP:ADP ratio does not occur.
Next, to further investigate the role of ARNT/HIF-1β in GSIS, metabolic proling of
the glycolytic, pentose phosphate, TCA cycle, free fatty acid, and amino acid pathways in
both siControl and siARNT1 cell lines were carried out. Here we summarize the eect on
glycolytic and TCA cycle pathways, since these pathways are subject of interest in current
work. This comparative analysis revealed that glycolytic intermediates were signicantly
reduced in siARNT1 cell lines. Interestingly, glucose-6-phosphate level was not aected
by the knock-down, indicating that the activity of glucokinase is unaected in siARNT1
treated cells. This observation is consistent with the result that glycolytic ux is unaected
in siARNT1 treated cells. However, other glycolytic intermediates, dihydroxyacetone phos-
phate, 3-phosphoglycerate, pyruvate, and lactate are signicantly reduced both at basal
and stimulatory glucose concentration in siARNT1 treated cell lines. The TCA cycle in-
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termediates also showed marked decrease in metabolites concentration in siARNT1 cells
compared to siControl cells. At stimulatory glucose concentration there was signicant re-
duction in α-ketoglutarate (90±5%), succinate (68±2%), fumarate (67±1%), and malate
(65±2%). Citrate showed less marked reduction of 49±8%. These metabolites are known
to be important participants in pyruvate recycling which is known to be correlated with
the amplifying pathway.
To further investigate the eect of ARNT/HIF-1β silencing, gene proling of several
genes involved in diabetes, glucose metabolism and pyruvate recycling was carried out.
Here we outline the eect on ARNT/HIF-1β silencing on the pyruvate recycling pathway.
Pyruvate carboxylase and pyruvate dehydrogenase were signicantly reduced in response
to ARNT/HIF-1β silencing. Moreover, the transport proteins DIC and OGC were signif-
icantly reduced in siARNT1 treated cells. Other important enzymes involved in pyruvate
recycling, MEc and ICDc, were proled. Out of the two, only MEc expression was reduced
in response to ARNT/HIF-1β silencing; ICDc was unaected. All these components are
proposed to be important participants in the amplifying pathway. Putting all the infor-
mation together we can conclude that ARNT/HIF-1β plays an important role in GSIS.
2.6 Possible Metabolic Coupling Factors
Several metabolic coupling factors (MCFs) have been proposed as potential activators of
the second phase of insulin release (the amplifying pathway). Recent studies suggest that
NADPH is the most important signaling molecule. Here we review the evidence supporting
this hypothesis.
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As discussed in the previous section, 13C-isotopmer analysis of INS-1 derived cell lines
revealed that recycling of pyruvate across the mitochondrial membrane correlates well
with glucose responsiveness. Two enzymes of the pyruvate recycle pathway, ICDc and
MEc are producers of NADPH. Evidence emerged from the siRNA studies showing that
the NADPH:NADP ratio correlates with insulin secretion [88]. Furthermore, PC activity
in β-cells is high (approximately 40-50% of pyruvate enters the TCA cycle through PC),
and PC converts pyruvate into oxaloacetae, which can be subsequently converted into
malate through reactions catalyzed by malate dehydrogenase (MDH). Malate participates
in a number of reactions involved in pyruvate recycle(Figure 2.7). Signicant among them
is the transport of malate to the cytosol, by the malate-Pi antiporter (DIC), where it
can be converted to pyruvate via cytosolic malic enzyme with CO2 and NADPH as by-
products. Pyruvate can then be transported back into the mitochondria via a pyruvate-
H+ symporter (PYC) from which the cycle continues. Furthermore, NADPH reducing
equivalents can also be exported from the mitochondria as citrate and isocitrate. Finally,
NADPH participates with enzymes outside the pyruvate recycle pathway which are known
to be insulin potentiators [82]. For example, nitric oxide synthase, which is known to




































Possible MCF are NADPH, GTP , 
GTP Cytosol
NADPH
Knock down of these enzymes affects the insulin secretion
Knock down of these enzymes does not affects the insulin secretion
Figure 2.7: Schematic illustration of MCFs generated through the pyruvate recycling path-
way. Red crossed ovals show enzymes whose silencing aects glucose stimulated insulin se-
cretion (GSIS); green crossed ovals show enzymes whose silencing had not eect on GSIS.
The red boxed region highlights the fact that knock-down of ICDc, which produces NADPH
as co-factor, signicantly aected GSIS.
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Chapter 3
Kinetic Modeling and Model Analysis
Chapter Outline In this chapter we present a brief summary of the procedures used to
build kinetic models. Firstly, we describe how to develop kinetic models from available in-
formation about metabolic pathways. Second, we introduce stoichiometric analysis, which
is relevant for addressing basic properties of kinetic models (and can provide a useful con-
sistency check). Finally, we conclude by presenting methods for local sensitivity analysis
(LSA) and global sensitivity analysis (GSA) of kinetic models.
3.1 Development of Kinetic Models
Metabolism is a highly organized and regulated cellular process, involving thousands of
enzyme-catalyzed reactions. A series of reactions in which one metabolite is transformed
into another is known as a metabolic pathway; for modelers the dynamics of these pathways
is of particular interest. Modeling allows the identication of control points in pathways,
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and describes the dynamic behavior of pathway metabolites. The development of a ki-
netic model involves the identication of the metabolic pathway, the determination of the
associated enzyme kinetics (including regulation), and the construction of a system of dif-
ferential equations. These equations can be used to investigate properties of the system
using methods such as local sensitivity analysis (LSA) or global sensitivity analysis (GSA).
Every modeling task starts with some assumptions. The rst basic assumption we
make in kinetic modeling is that each organelles is a dierent compartment, and each com-
partment is well mixed. Reaction rates can then be assumed to follow the law of mass
action, according to which the reaction rate is proportional to the probability of collision
of reactants, which, in turn, is proportional to the concentration of reactants to the power
of their molecularity. We then formulate rate equation as follows,
d[X]
dt
= Rate of production of [X]− Rate of consumption of [X]
Here [X] designates any compound involved in either a metabolic pathway or in transcrip-
tion or translation processes.
Pathway Identication To construct a kinetic model, the rst task is to identify the
biochemical pathway which will be the subject of investigation. This task is facilitated by
a series of well-curated databases, like KEGG [54], Reactome [68, 109], UniPathway [75]
and many more. (A comprehensive list of biology-related databases is published every year
in Nucleic Acid Research Database issue.) These databases provide detailed descriptions
of the biochemical reactions in each pathway, through which we get the details of the
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molecular mechanism (e.g., enzyme catalytic cycle). These details include
 The identity of all components of the metabolic pathway.
 The intracellular location and components of each reaction (e.g. all the possible
states of the proteins involved).
 The kinetic mechanism of action of each reaction in the pathway.
Once the details of the metabolic network have been identied, the next task is to assign
values to the kinetic parameters involved in the pathway reactions. There are curated
databases that catalog the kinetic data of enzymes and biochemical reactions. Brenda [95,
98] and EMP database [102] are the two databases which have the most comprehensive
enzymological data related to kinetic description of enzymes. SABIO-RK [112, 113] is
database that catalogues information about biochemical reactions, their kinetic equations
(with parameter values), and the experimental conditions under which these parameters
were measured.
Once these details are collected the details of mechanism of action (i.e. rate expressions)
of each reaction can be incorporated into the model. We next review the basics of enzyme
kinetics, which provide a foundation for describing the rates of metabolic reactions.
3.1.1 Introduction to Enzyme Kinetics
Enzymes are the house-keepers of biological processes. The mechanisms through which they
catalyze biochemical reactions demand special mathematical treatment. Enzyme catalysis
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involves multiple stages of enzyme-substrate interaction; to formulate the mechanism en-
zyme catalysis we will make some simplifying assumptions. These assumption enable us to
take into account the diversity of dynamic and regulatory properties of dierent enzymes.
The main features of these approaches are described below [17, 14, 30].
In 1902 Adrian Brown [43] proposed that an enzyme-catalyzed reaction is composed
of two elementary reactions in which substrate forms a complex with the enzyme, which
subsequently decomposes into product and enzyme:
[E] + [S]
 [ES]→ [P ] + [E] (3.1)
Here, [E], [S], [ES], [P ] symbolize the enzyme, substrate, enzyme substrate complex and
products respectively. Let k1 be the rate of the forward reaction and k−1 be the rate of the
backward reaction for the rst stage (that is, for the reaction [E] + [S] 
 [ES]). Let k2
be the rate of the forward reaction for the second step of the reaction (that is, for reaction
[ES]→ [P ]+[E]). The time-course of the individual reactant concentrations are expressed
by the dierential equations,
d[S]
dt
= −k1[S][E] + k−1[ES] (3.2)
d[E]
dt
= −k1[S][E] + (k−1 + k2)[ES] (3.3)
d[ES]
dt





where the last equation describes the rate equation for the product formation, also called
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the reaction velocity v. This reaction rate is directly proportional to [ES], the concentration
of the enzyme substrate complex. In practice, we need to express the reaction rate v in
terms of the concentration of [S] because [ES] is not known. We make two simplifying






















Figure 3.1: Time-course for the components of a simple Michaelis-Menten reaction. After
the initial transient, the slopes of [ES] and [E] are essentially zero so long as [S] [E]T [30]
(as represented by the box).
To simplify this system, Lenor Michaelis and Maude Menten, building on the previous
work of Victor Henri, proposed in 1913, the idea of using a rapid-equilibrium assumption.









Here KS is dissociation constant.
In 1925 G. E. Briggs and J. B. S. Haldane [8] provided an alternative mechanism, called
the quasi-steady state assumption, to solve the system. Referring to Figure 3.1 we observe
39
that for reasonable length of time concentration of [ES] is nearly constant, since formation




Based on the above quasi-steady state assumption we present the derivation of reaction
rate v as follows,
Conservation equation [E]T = [E] + [ES] (3.8)
so that
[E] = [E]T − [ES] (3.9)
Combining steady state assumption of equation 3.7 and this conservation equation we
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substitute for [E] in 3.4. We then get,
k1([E]T − [ES])[S] = (k−1 + k2)[ES] (3.10)
Which on rearrangement becomes (3.11)
[ES](k−1 + k2 + k1[S]) = k1[E]T [S] (3.12)




+ [S]) = [E]T [S] (3.14)























We now dene the limiting rate (maximal velocity) of the reaction as follows. (3.21)
Vmax = k2[E]T (3.22)





Referring to Figure 3.2, the Michaelis constant Km represents the concentration at which
the reaction velocity is half maximal. Therefore enzymes with small Km values will achieve
maximum catalytic eciency at low concentration of substrate. The limiting rate of the
reaction, Vmax, occurs at high substrate concentrations, when enzyme is saturated. The
units of the Michaelis constant Km are concentration; Vmax has units of concentration per
time.
Estimation of kinetic data To estimate the values of parameters Vmax and Km for
an enzyme, one measures the initial rates for dierent initial substrate concentrations.
Since the rate is non-linear, one has to determine the parameters by non-linear regression.
Another approach is to transform to a linear relation between variables and then apply
linear regression.















Figure 3.2: Illustrative plot of the turnover rate v0 of Michaelis-Menten reaction versus the
substrate concentration [S].
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Figure 3.3: A Lineweaver-Burk plot. Note the crowding of points at large [S].
Hofstee [21] and Hanes and Woolf [31] have proposed alternative way of linearizing the
rate expression, but they are also not free of limitations. More details can be found in the
book by Cornish-Bowden [14]
Derivation of Fumarase Enzyme Kinetics The derivation in the previous section
described the idealized case of an irreversible, one-substrate reaction. To illustrate a more
complex catalytic mechanism, we next derive the rate expression of the fumarase enzyme.
The reaction is assumed to be reversible, with one substrate (fumarate) and one product
(malate). The reaction is competitively inhibited by citrate, ATP, ADP, GTP, and GDP.
First we will derive the mechanism for single inhibition by ATP and then generalize the
formula to include the rest of the inhibitors.



















Figure 3.4: Fumarase Mechanism
Similarly let K2 and K−2 be the rates for EFUM dissociating to E and MAL and re-
associating, and let K3 and K−3 be the rates of formation/dissociation of the inhibited
complex E − ATP .
The enzyme and enzyme-substrate concentrations are then described by
d[E]
dt
= K−1[EFUM ]−K−2[E][MAL] +K−3[EATP ]−K1[E][FUM ]−K3[E][ATP ]
d[EFUM ]
dt
= K1[E][FUM ] +K−2[E][MAL]−K2[EFUM ]−K−1[EFUM ]







Using conservation, we have
[E] + [EATP ] + [EFUM ] = [E]t (3.26)
where [E]t is the total enzyme concentration, presumed xed. The binding of inhibitor is

















) + [EFUM ] = [E]t (3.29)
Now combining the value of [E] from the steady state assumption and the conservation
equations, we get the value of [EFUM ] as
[EFUM ] =
[E]t(K1[FUM ] +K−2[MAL])
(K−1 +K2)α +K1[FUM ] +K−2[MAL]
(3.30)
Let α = 1 + [ATP ]
KiATP
The reaction rate v is given as
v = −d[FUM ]
dt
= K1[E][FUM ]−K−1[EFUM ] (3.31)
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Substituting the value of [E] and [EFUM ] and rearranging, we arrive at
v =
[E]tK1K2[FUM ]− [E]tK−1K2[MAL]
(K−1 +K2)α +K1[FUM ] +K−2[MAL]
(3.32)
Now let Vmf = K2[E]t and Vmr = K−1[E]t.
Then,
v =
K1Vmf [FUM ]− VmrK−2[MAL]
(K−1 +K2)α +K1[FUM ] +K−2[MAL]
(3.33)


















Discussion This equation 3.34 describes the turnover rate of fumarase. It can be ob-
served that when α = 1, equation 3.34 reduces to the case of un-inhibited reversible
Michaelis-Menten kinetics. As α increases (Figure 3.6) it aects the KM value, but does
not aect the Vmax. In other words, the larger the value of α, the greater the substrate con-
centration needed to approach Vmax. If there are multiple inhibitors, then only α changes;















Figure 3.5: Illustration of eect of inhibition coecient α on Km. α = 1; Km, α = 2; Km',
α = 3; Km''













In this case α is given as:


















Many proteins, including enzymes, have multiple binding sites where a molecule, generically
called a ligand, can bind; these binding processes may cause interactions between the
binding sites themselves. Consider the simple case where one ligand molecule (S) binds to
a protein (E) with one binding site:
[E] + [S]
 [ES]





The dissociation constant KD is dened as the reciprocal of KB. The total number of
binding sites that have bound ligands, divided by the total number of sites is called the









KB · [S] + 1
(3.37)
Given that [E]total = [ES]+ [E] and using equation 3.36 [E] =
[ES]
KB ·[S]
. The plot of Y vs S is
hyperbola (Figure 3.6). Now, if the the protein has several binding sites, then interaction
between these sites may occur: the anity to further ligands may change after binding
of one or more ligands. This phenomena is called cooperativity. Positive cooperativity
increases the anity of ligand to bind to the site whereas negative cooperativity decreases
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the anity of further ligands to bind on the sites.
Next we derive the expression for a dimeric protein with two identical binding sites
exhibiting cooperativity. We start with the assumption that binding of the rst ligand











2[E2] + 2[E2][S] + 2[E2][S2]
(3.39)
Let us put further assumption that the anity to the second ligand is strongly increased
by binding to the rst ligand, then [E]2[S] will react with [S] as soon as it is formed, and
the concentration of [E2][S] can be neglected. This assumption of complete cooperativity
(i.e every protein is either empty or fully bound) leads to:
[E2] + 2[S]→ [E2][S2] (3.40)


















Under these assumptions, for a protein with n binding sites, one can derive an expression
of the form





Where n is referred to as the Hill coecient. This is referred to as a Hill function [38].
It implies that the binding to a certain ligand inuences the anity of the protein to
















Figure 3.6: Plot of hill kinetics. n < 0 < 1 is cooperative inhibition; n > 1 is cooperative
activation; n = 1 is Michaelis-Menten rate.
mitochondrial isocitrate dehydrogenase enzyme and succinyl-CoA dehydrogenase.
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3.1.3 Allosteric Enzymes
Allosteric (Greek allos, other + stereos solid or space) enzymes are the class of enzyme
which have extra binding sites other than the active (catalytic site). At these additional
sites, small molecules such as metal ions can bind; this binding event has a regulatory
eect on the catalytic activity of enzyme. The binding can induce the enzyme to catalyze
more eciently, or can have an inhibitory eect, where the catalytic eciency of enzyme
is reduced (Figure 3.7). Furthermore allosteric enzymes can incorporate cooperative reg-
ulation. Therefore, the kinetics of allosteric enzymes requires special treatment, since the
complete mechanism cannot be explained just by Michaelis kinetics or the Hill equation.
Here we review the Monod et al. [73] model of allosteric regulation. We will not derive
the expression but discuss the properties of the rate expression. The Monod model is based
on the assumptions that:
 All the n enzyme sites are identical.
 Each sites belongs to a sub-unit. These sub-units have two conformational states:
active (R) or inactive (T).
 All the sub-units change their conformations at the same time.
 The equilibrium constant between R and T conformations is called the allosteric













Figure 3.7: Schematic illustrate of allosteric enzymes and eect of allosteric modier.
Binding of the allosteric modier to the allosteric site modies the active site making the
enzyme inactive. This is allosteric inhibition . Similarly, allosteric activation is possible.
Next, binding constants for the active conformations are given by KR and for inactive
conformation by KT . Let us assume that substrate molecules can bind only to the active









where the factor VmaxKR[S]
1+KR[S]




is a allosteric regulatory factor.
For L = 0 the plot V vs S is a hyperbola as in Michaelis-Menten kinetics; For L > 0
one gets a sigmoid curve shifted to the right.
For the general case where substrate can also bind to the inactive state (that is KT 6= 0)














So far we discussed positive regulation involving cooperativity. Now we discuss allosteric
activation and inhibition. For that we need to modify the L . Consider the case in which
an activator [A] binds only to the active conformation and an inhibitor [I] binds only to
the inactive conformation. This will shift the equilibrium to the respective conformation.






KI and KA denote binding constants. An activator molecule decreases the sigmoidity while
an inhibitor molecule increases the sigmoidity. The plot of the rate expression for dierent
cases is shown in gure 3.8.
In the current study there are many allosteric enzymes, such as Pyruvate dehydroge-


















Figure 3.8: The plot of equation 3.45 for dierent values of L. Parameters are Vmax = 1, n =
4, KR = 2, KT = 0. Values of L are shown in legend. We can observe that increasing the
value of L causes strong sigmoidity. Also, shown are the eect of activators and inhibitors,
with dashed and dotted line respectively. The value of L = 104 for this case and KI [I] = 1
in equation 3.47 for inhibition and KA[A] = 1 for activation.
to ions (Ca2+) or the ATP:ADP ratio; when these species are treated as constants, the
allosteric terms reduce to single parameters. In the model described in Chapter 5, allosteric




Transporter proteins are a special class of membrane-embedded enzymes that selectively
transport metabolites across the plasma membrane without any chemical modication to
the molecule. Transporters are of two types: active and passive. Active transporters require
energy to transport the molecule, while passive transporters require no energy expenditure.
In the current study only passive transporters are involved. Passive transporters can be
modeled in the same way as enzyme-catalyzed reaction, with substrate and product being
the same metabolite but in dierent compartments. For all the four transporters in the
model in chapter 5, the pyruvate transporter, citrate-isocitrate carrier, dicarboxylate carrier
and the oxaglutarate carrier, the transporter kinetics is described by the rapid equilibrium
random-bi-bi enzyme kinetics, as previously modeled in Yugi and Tomita [116]. There
are two sub-types of transporters: antiporters, which transport the two metabolites in
opposite directions, and symporters, which transport the two metabolites in the same
direction (Figure 3.9).
The overall reaction scheme of the rapid equilibrium random-bi-bi enzyme kinetics is
shown in gure 3.10. The derivation of rate expression follows the same steps as outlined
for the fumarase kinetics. These complex rate expression need not be manually derived
,as there are many software tools available to carry out the derivation automatically such








































Figure 3.9: Schematic illustration of antiporter and symporter transporters across the
plasma membrane
where v{·} are the forward and reverse turnover rates of the enzyme and Ki{·} are the
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Figure 3.10: The overall reaction scheme for a rapid equilibrium random Bi-Bi kinetic
reaction
3.2 Structural Analysis of Metabolic Pathways
We next review some properties of kinetic models that can be understood by analysis of the
stoichiometry matrix. These are sometimes known as structural properties of the metabolic
pathway. These analyses are valuable as a consistency check of the model, by identifying
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metabolite conversation in the pathway. Conservation analysis can lead to simplication
of the system of ODEs which can lead to more ecient solution.
Stoichiometry coecients are dened as the proportion of substrate and product
molecules involved in a reaction. For example, consider the simple reversible reaction
A 
 B where A and B are two chemical species. For this reaction, the stoichiometric
coecient of A is -1 and for B is 1. The stoichiometry matrix is constructed from the
stoichiometric coecients of all reactions within a pathway. This matrix is organized in
such a way that every column corresponds to a reaction and every row corresponds to a
compound. The stoichiometric matrix for above reaction is simply [1,−1]T . It is impor-
tant to note is that the assignment of the stoichiometric matrix is not unique, since the
ordering of the species and reaction can be re-arranged. For a metabolic pathway having
m metabolites and r reactions, the stoichiometric matrix is a matrix N of size m× r.
Systems Equations Consider a metabolic pathway consisting of m species and r reac-






nijvj for i = 1, ....m (3.49)
where nij is the stoichiometric coecient of metabolite i in reaction j and vj is the j
th
reaction rate.
Now, we build a stoichiometric matrix N from stoichiometric coecients nij assigned
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to the substance Si and the reactions vj as:
N = nij for i = 1, ...,m and j = 1, ..r (3.50)
Here, each column belongs to a reaction and each row to a substance.
Let us dene a metabolic pathway with concentration values vector as S = (S1, .....Sn)
T ,
reaction rates vector v = (v1, ...vr)
T and a parameter vector p = (p1, .....pm)
T with the
stoichiometric matrix N . If the system is in steady state, we can also consider the vector
J = (J1, J2, ....Jr)
T containing the steady state uxes. With this notation putting the




Properties of the Stoichiometric Matrix N Analysis of the matrix N can reveal
important information about the structural properties of the pathway. Analysis of the
stoichiometric matrix can identify which combinations of individual uxes are attainable
in steady state. Moreover, dead-ends and un-branched reaction pathways can easily be
calculated from stoichiometric matrix. Furthermore, we can discover the conservation
relations in the pathway.
Supposing that equation 3.51 is in steady state, we have:
dS
dt
= Nv = 0 (3.52)
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The product Nv is a linear system of equations that constrains the reaction rates v. This
equation has nontrivial solutions only for rank N < r. Next, we dene the kernel matrix
K such that
NK = 0 (3.53)
Equation 3.53 describes linear dependencies among the reaction rates. The kernel matrix
K is not unique. Equation 3.53 can be solved using, e.g. Gaussian elimination [86]. Every





αi · ki (3.54)
The coecients must have appropriate units (M · s−1 or mol ·L−1 · s−1 ). Now we can
analyze following properties of the metabolic pathway
1. If the entries in a certain row are zero in all basis vectors, we have found an equilibrium
reaction. In any steady state, the net rate of the respective reaction must be zero.
2. If all basis vectors contain the same entries for a set of rows, this indicates an un-
branched reaction path. In each steady state, the net rate of all respective reactions
is equal.
In the previous analysis all the reactions are considered to be reversible reactions. If
a reaction is irreversible then extra constraints are to be put on the kernel matrix K, but
the stoichiometric matrix N remains unchanged. Extra conditions can be placed on the
set of vectors belonging to K such that some values may not become negative or positive
depending upon the way ux direction is dened.
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Identication of Conservation Relation from Null Space of NT Now we explain
the derivation of conservation relations in metabolic pathways. If the total concentration
of substance remains constant, which can be the case where substance is neither added or
removed from the reaction system then the substance is conserved in the reaction system.
The conservation will be preserved even if the substance interacts with the other substance
and forms a complex.
To identify conservation in metabolic pathway we start by dening a matrix G such
that:
GN = 0 (3.55)
Substituting in equation 3.51, we have
GṠ = GNv = 0 (3.56)
Integrating this equation we have the conservation relations:
GS = const (3.57)
where, n is the number of metabolites in the system. Furthermore, the number of
linearly independent rows of G is equal to n − rank(N). GT is the kernel matrix of NT ,
having properties similar to kernel matrix K. The matrix G can also be calculated using
Gaussian elimination [86]. Matrix G is not unique, since every linear combination of its
rows is again a valid solution.
Conservation analysis is very important in the context of kinetic modeling, as identica-
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tion of conservation relations will lead to simpler ODE system. To carry out the reduction
rst the rows of the stoichiometric matrix N and its concentration vector S are reordered
in such a way that all the independent rows are at the top and dependent rows are at
the bottom. This way of splitting the matrix into a linearly independent part N0 and a
dependent part N ′ can be carried out. Therefore, the system of equation can be written
as follows:
N = (N oN ′) = LN o = (Irank, NL
′)N o (3.58)
where, L is called the Link matrix
Where, Irank(N) is the identity matrix of size rank(N). The system of dierential equation
becomes:
Ṡ = (Ṡindep Ṡdep) = (Irank(N)L′)N
ov (3.59)
and the dependent concentration satises
Ṡdep = L
′ · Ṡindep (3.60)
Integration leads to
Sdep = L
′ · Sindep + const (3.61)
This relation holds true for the entire time course. Thus we may replace the original
system by a reduced equation system
Ṡindep = Nov (3.62)
63
This equation together with the set of algebraic equations describes the complete system
dynamics. These elementary stoichiometric analyses are useful to identify conservation if
present in the model which might not be implicit in the model structure and to check the
system of dierential equations.
3.3 Local Sensitivity Analysis
To study the eect of individual parameter perturbation on the model output, the method
of local sensitivity analysis is used (LSA). In this section we summarize steady state LSA
of kinetic models.
Consider quantity y(x) which depends on another quantity x. The local eect of a










For example, Mx might be e.g. a one percent change of x. The normalization factor x/y
makes the coecient independent of units and of the magnitudes of x and y. The advantage
of having unit-independent coecient is that sensitivities can be compared across dierent
reactions. However, normalization is not possible if y = 0, which may happen for certain















We next review two interpretations of the LSA coecient: the ux control coecients and
response coecients of metabolic control analysis (MCA). For a comprehensive description
of MCA, readers are referred to excellent texts by Fell [24], Klipp et al. [60], and Heinrich
and Schuster [35].
3.3.1 Sensitivity Coecients
Flux Control Coecients Before we dene the sensitivity coecients of MCA it is
important to emphasize that all this analysis has the strict condition that the metabolic
pathway is operating at a stable steady state. Let us consider the steady state concentration
S = S(p) and steady state uxes J = v(S(p), p) of the pathway. In the limit of a very
small perturbation of an individual reaction rate by a parameter change vk → vk+ M vk,
we drive the system to a new steady state with J → J + ε1J and S → S + ε2S. The ux















The control coecients measure the control that a given reaction vk applies on the steady
state ux J or on the steady state concentration Si, respectively. It is assumed that the




6= 0 and ∂vl
∂pk
6= 0 (l 6= k) (3.68)
This parameter might be the enzyme concentration, a kinetic constant or the concentration







Response Coecients To understand the eect of generic kinetic parameter pm other
than enzyme concentration (i.e. Vmax) Kascer and Burns [53] dened the Response Coe-
cient. They assumed that the parameter inuences the behavior of the system, but can be
held constant after it has been altered while the system reaches a new steady state. The












where the rst coecient expresses the response of the ux to a parameter perturbation
while the latter describes the response of a steady state concentration.
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3.4 Global Sensitivity Analysis
As more and more experimental data become available, the size of published kinetic models
also increases. Often, many parameters are derived from dierent cell types and exhibit
signicant experimental error. Furthermore, a subset of these parameters are not t directly
to data, but instead are calibrated to reproduce experimental observations of the system
for which the kinetic model is developed. As a consequence, kinetic parameters often have
signicant uncertainty associated with their values. Furthermore, biochemical regulation
is a very complex mechanism, exhibiting multiple ways of regulating biochemical process.
Thus, the study of interaction between parameters can lead to important identication of
model behavior. In other words, a individual parameter might not have a signicant eect
on model behavior in isolation, but in combination with certain parameters, could lead to
important change in model behavior. Through local sensitivity analysis, we cannot study
model behavior that can account for these eects, as local sensitivity is limited to individual
parameter perturbations. So, we need new analysis methods through which we can study
the associated uncertainty with parameters and interaction eects among parameters. For
this purpose, global sensitivity analysis (GSA) is a very eective analysis method.
One denition of GSA, according to Salteli et al., is: The study of how uncertainty in
the output of a model (numerical or otherwise) can be appropriated to dierent sources
of uncertainty in the model input. For model analysis, we made use of the Partial rank
correlation coecient (PRCC), the variance-based GSA method; the extended Fourier
amplitude sensitivity test (eFAST), and Sobol's method. The reason for using multiple
sensitivity analysis is that the GSA sensitivity measures depend on the method used, and
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comparative study of the sensitivity measures of dierent methods can lead to identication
of important model behavior. Details about the mathematical background of the methods





Chapter Outline In this chapter we will present the brief overview of mathematical
methods used in the project. First, we summarize the dynamic parameter identication
using the simplex algorithm and the simulated annealing algorithm (SA). Then we will
discuss the steady state calculation using a combination of an ODE solver and nonlinear-
equation solvers. Second, we summarize the methods of derivative approximations used
during the project. Third, we summarize the methods of global sensitivity analysis (GSA)
used in the project. Finally, we conclude with a proposal to use a surrogate modeling
frame work for parameter identication in large kinetic models.
4.1 Parameter Identication
In this section we will describe parameter identication procedures for ordinary dierential
equation (ODE) kinetic models. We used two optimization algorithms: Nelder-Mead [79]
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and simulated annealing algorithm (SA) [59] for the purpose of parameter identication.
Here, we will summarize the these two algorithms. Next, we describe the MATLAB®
ODE15s function algorithm which was used to solve the ODE. Finally, we explain the
MATLAB® fsolve function algorithm which was used to achieve a steady state solution.
Objective Function Let us rst describe the mathematical frame-work for an ODE
based kinetic models. A Kinetic model of a metabolic pathway can be described by the
following continuous ordinary dierential equations:
ẋ = f(x(t), u(t), p), (4.1)
x(t0) = x0,
y(t) = g(x(t))
Where x ∈ Rn is the systems state vector (metabolite) for a metabolic pathway, p ∈ Rk is
the system parameter vector, u(t) ∈ Rp is the system input, y ∈ Rm denotes the measured
data, and x0 is the initial state. f(·) is a set of functions describing the dynamical properties
of a biological system like rate expressions. Finally, g(·) represents a measurement function
such that if all the states are known then g(·) becomes an identity matrix. Otherwise,
corresponding rows are deleted from In whose experimental values are unknown.
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ˆ̇x(tj) = f(x̂(tj|p̂), u(t), p̂), x(t0) = x̂0,
ŷ(tj) = g(x̂(tj|p̂)), j = 1, 2, ......N − 1
pl ≤ p̂ ≤ pu
OBJ0 measures the tness of the model with respect to given experimental data, where
p̂ ∈ Rk is the set of parameters to be identied, || · ||l denotes the l-norm with l > 0, x̂0 is
the estimated initial condition, x̂ ∈ Rk is the estimated system states x̂(tj|p̂) represents the
estimated variable at tj with parameter p̂ and initial condition x̂0, wij are the weighting
coecients, ŷ is the estimated measured data. Finally, pl and pu are lower and upper
bounds on the parameters and are also referred to as box constraints.
To minimize OBJ0 a number of optimization algorithms can be used. Special attention
needs to be paid to the fact that the derivative of the cost function is not easily available
and accuracy is limited since derivatives needs to be evaluated at each iteration. In the
concluding section of this chapter we will discuss ideas about solving the problem more
eciently.
The objective function dened in equation 4.2 is the generalized statement of kinetic
model parameter estimation. The objective function used to estimate the parameter in the
current study is discussed in Appendix A.2.2.
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4.1.1 Optimization Algorithm
Here we describe two algorithms which we used to estimate parameters as described
Press [86] and implemented in SBTOOLBOX2 [97].
Simplex Algorithm Nelder and Mead [79] in their pioneering work developed a deriva-
tive free optimization algorithm for multidimensional unconstrained (box constraints can
easily be included) optimization. Since the method does not require derivative informa-
tion, the method is suitable for problems involving non-smooth functions and parameter
estimation problems of ODEs.
We use the notation of the Conn et al. [12]. The Nelder-Mead [79] algorithm is designed
for classic nonlinear unconstrained minimization of a nonlinear function f : Rn → R.
Nelder-Mead [79] is simplex based method where a simplex S in Rn is dened as the
geometrical gure consisting in N dimension of N+1 points and all their interconnecting
line segments [86]. For example, in two dimension simplex is a triangle, in three dimension
it is tetrahedron, not necessarily a regular tetrahedron. In other words a simplex S in R
is the convex hull of N + 1 points (vertices's) y0, . . . , yn ∈ Rn [12]
A simplex based method begins with a set of N + 1 points y0, . . . , yn ∈ Rn that are
considered as the vertices's of a working simplex S, and the corresponding set of function
values at the vertices's fi = f(yi) for i = 0, . . . , n given constrain that working simplex
S is non-degenerate that is the points y0, . . . , yn must not lie in the same hyperplane. With
in these mathematical constraints the algorithm performs a sequence of transformations
of the working simplex S, in order to decrease the function values at its vertices's. At
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Figure 4.1: Simplex in 2 and 3 dimensions.
each iteration a series of test points are calculated together with function values, and then
function values are compared based on which transformation is determined.
Description of Algorithm The initial simplex S is generally constructed by generating
n+1 points around y0, . . . , yn around a given input point yin ∈ Rn. Press [86] recommends
that this point be chosen to be y0 = yin since this can allow proper restart of the algorithm.
The remaining n points are then constructed based on:
 S is right angled at y0 based on coordinate axes, or
yi = y0 + δiei, i = 1, . . . , n (4.3)
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where δi is the step size in the direction of unit vector ei ∈ Rn
 S is a regular simplex, where all edges have the same specied length.
Next, the Nelder-Mead method takes series of steps or transformations in order to
move the points of the simplex such that function value is lowest among all simplex point.
These steps transformations are called reections and to maintain non-degeneracy they
are constructed in such a way to preserve the volume. Under this assumption, the method
expands the simplex in one or another directions to take larger steps. Next, depending
on the function value the method contracts itself: in the transverse direction if encounters
valley or contracts itself in all direction if the function value is decreasing sharply.
Stopping Criteria Termination criteria in any multidimensional minimization routine
should be decided with signicant care. Two set of criteria usually works best for the
optimization. First, optimization can be terminated when the vector distance moved in
the current step is fractionally smaller in magnitude than some tolerance tol. Second, we
could require that the decrease in function value in the terminating step be fractionally
smaller than some tolerance ftol. Press [86] recommended that tol should not usually be
smaller than the square root of the machine precision, but it is perfectly appropriate to let
ftol be of order the machine precision.
In derivative free methods like the Nelder-Mead stopping criteria can easily return
wrong solutions or stop prematurely before reaching actual minima. Nevertheless, the
stopping criteria in derivative-free methods are an active area of research. The simplest
work around to overcome this problem is to restart a multidimensional minimization routine
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at a point where it claims to have found a minimum. Press [86] suggests that for this
restart re-initialization can be done through any ancillary input quantities. For example,
the downhill simplex method can be reinitialized at any of N of the N+1 vertices's of the
simplex again by equation 4.3 y0 being one of the vertices's of the postulated minimum.
Convergence The convergence analysis of the Nelder-Mead method is a nontrivial prob-
lem and is currently actively pursued. The details of the convergence properties of the
Nelder-Mead method can be found in the book by Conn [12].
Simulated Annealing (SA) The method of SA is inspired from the thermodynamics
process called annealing. In the annealing process, liquids are heated and cooled slowly.





where, k is Boltzmann's constant, E is the energy of the state and T is the temperature.
The physical meaning of the Boltzmann equation is that a system in thermal equilibrium
at temperature T has its energy probabilistically distributed among all dierent energy
states E. In the transitions the system looks for the minimum energy states or in other
words this to minimize its energy. Metropolis et al. [71] used these principles to simulate a
thermodynamic system such that the system makes transitions from energy E1 to energy
E2 with probability p = exp[− (E2−E1)kT ] with the condition that if E2 < E1 then p = 1 (since
in this case probability is greater tha 1). Now, a thermodynamic system makes both high
energy transitions and low transitions eventually nding its minimum energy state. This
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is called the Metropolis algorithm.
Kirkpatrick et al. [59] using same idea introduced a minimization algorithm for non-
thermodynamic systems which is known as simulated annealing algorithm (SA). In the
Kirkpatrick et al. paper this algorithm was used to solve a discrete problem, however the
SA can easily be extended to continuous system with the some renements. Consider, the
continuous function f(x) such that x ∈ Rn. To minimize f we have to reformulate SA as
follows:
 The f is the objective function.
 The system state is now x.
 The control parameter T is like a temperature with an annealing schedule by which
it is gradually reduced and there must be a generator of random changes in the
conguration that is the procedure for taking a random step x to x+ M x
Implementation of SA The SA algorithm is implemented as the simplex algorithm with
the dierence that the next simplex move is decided by the SA algorithm. The algorithm
includes the box constraints. Complete details of the computational implementation can
be found in Press [86]. The method is implemented in SBTOOLBOX2 [97] with box
constrained (that is bounds on x) which was used for parameter estimation in the current
study.
It is important to discuss the annealing schedule of SA algorithm, since the success
of SA depends signicantly on the type of annealing schedule used. Next, we discuss an
annealing schedule tried during parameter optimization as recommended in Press [86]:
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1. The decrease in T is scheduled in such a way that T reduces by (1− ε)T after every
m moves, where ε/m is determined by heuristics.
2. T is assigned a value using T = T0(1− kK )
α after everym moves, where α is a constant
values that can be chosen between 1 and 4, k is the cumulative numbers of moves
thus far, K is preassigned total number of temperature reductions. While choosing
the value of α it should be considered that a larger value of α implies larger spent
time at lower temperature.
3. Finally, schedule T reduction in T after m moves such that T reduces by the factor
of β · f1 − fb, where β is constant between 0 and 1, f1 is the smallest function value
of the current simplex, and fb is the best function so far achieved by the algorithm.
Important restriction is that the T should not be reduced more than some fraction
γ at a time.
Stopping Criteria and Convergence of SA The stopping criteria of the algorithm
in this implementation of SA is the same as discussed for Nelder-Mead algorithm. The
convergence results for SA algorithm are not yet available, however some discussion can
be found in the book by Laarhoven et al. [61].
SA oers many advantages suitable for kinetic model parameter estimation. First the
algorithm is not greedy that it is not tricked by the quick payo achieved by falling into
unfavorable minima. Provided that suciently general reconguration are given, it wanders
freely among local minima of depth less than about T. As T is lowered the number of
such minima qualifying for frequent visit is gradually reduced. Second, the conguration
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decisions tend to proceed in a logical manner. Changes that cause the greatest energy
dierence are shifted over when the control parameter T is large. These decisions become
more permanent as T is lowered and attention then shifts more to smaller renements in
the solution.
4.1.2 Solving the Model for Steady State
ODE solver In this section we discuss the backward dierentiation formula (BDF) for
solving a sti set of ordinary dierential equation (ODE).
The method can be used to solve an initial value problem of the type,
y′ = F (t, y) (4.5)
on a time interval [t0, tf ], given initial condition y(t0) = y0. More broadly these methods
can be used to nd solutions of the problem:
M(t)y′ = f(t, y) (4.6)
With a mass matrix M(t) that is non singular and sparse. However, our focus is on the
solution of equation 4.5
Implicit formulas for sti systems The BDF are very popular for solving sti ODE
problems. When the step size is a constant h and backward dierences are used, the
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∇myn+1 − hF (tn+1, yn+1) = 0 (4.7)
The simplied Newton method (chord) is used to solve the algebraic equation for yn+1.











This is the general formula for BDFs. In MATLAB® ODE15s the above formula is
implemented in a slightly modied form. Details about the implementation can be found
in Shampine and Reichelt [104]. We used the order 2 that is, k = 2, to solve the system of
ordinary dierential equations, since the order 2 oers maximum stability for the solver.
Next, The non-linear equation solver fsolve was used to check for the steady state reached
by the ODE solvers. Since, many times the solution returned by the ODE solver was
not the actual steady state so this check pointing was necessary for a consistency check
of the steady state. We used the Trust-region-dogleg method for solving the system of
non-linear equations. The details of the solver settings are documented in appendix A.2.1.
Since these methods are well established and not the subject of focus in the current work,
we will not discuss these methods in detail. The detailed description of the MATLAB®
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ODE suite and fsolve algorithm can be found elsewhere in [104, 83].
4.2 Derivative Computation
Numerical approximation of derivatives is required for sensitivity analysis, and for Jacobian
estimation for ODE and nonlinear equations simulation algorithms (and for derivative-
based optimization routines). In this section we outline three methods for approximation
of derivatives: dierence approximation, automatic dierentiation (AD), and symbolic dif-
ferentiation. In the current study, dierence approximation methods were used to evaluate
local sensitivity coecients, while AD and symbolic dierentiation were used for Jacobian
estimation for the implicit simulation of the ODE system.
4.2.1 Numerical Approximation of Derivatives
In this subsection we will review numerical approximation of derivatives, using the notation
of Elden et al. [22]. Let the function f be continuous and dierentiable. Suppose function
value is known for points x − h, x and x + h where h is a small number. Our goal is to
approximate the derivative f ′(x), that is, the slope of the tangent of the curve y = f(x) at
the point x. We can obtain a forward dierence, denoted D+(h), by approximating f by
the line through the points (x, f(x)) and ((x+ h), f(x+ h)) as follows (Figure 4.2),





Alternatively, we can dene the central dierence approximation, D0(h), as the slope of
straight line through the points ((x− h), f(x− h)) and ((x+ h), f(x+ h)) (Figure 4.2),
f ′(x) ' D0(h) =






central difference forward difference
function f(x)
Figure 4.2: Schematic illustration of dierence approximations.
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Approximation Error Next we present the error analysis of the dierence approxima-
tion. The dierence approximation has truncation error RT which can be approximated by
Taylor series approximation. Let f be a twice continuously dierentiable function, whose
rst derivative is approximated by forward dierence. Then:










(f(x) + hf ′(x) +
1
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where ξ denotes point in the open interval (x, x+h). ξ and f ′′(ξ) are unknown, but we can
observe that the truncation error is O(h) as h→ 0. This implies that if f ′′(x) is constant
for values close to x, then RT will be halved if the value of h is halved.
Let us keep the higher order terms of Taylor expansion then we get:

















. Similarly, for central dierence approximation we have:
D0(h)− f ′(x) = b1h2 + b2h4 + b3h6 + .... (4.14)
We observe given b1 6= 0 and bkb1 is not very large then we have RT ' b1h
2 provided h is
very small. It can be further observed that D0(h) gives better approximation compared to
D+(h) with exception for the case when a1  |b1| .
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Richardson Extrapolation Since, the dierence approximation was used to perform
the steady state local sensitivity analysis, we rened the results using the Richardson
Extrapolation method. Through this extra evaluation we can check for error in dierence
approximation due to ODE solver failure and if any discontinuity is present in the result.
This practice can increase our faith in the results especially for the large kinetic models.
We explain the Richardson Extrapolation using central dierence method 4.11 as de-
scribed in Elden et al. [22]. Consider the central dierence approximation
F (h) =
f(x+ h)− f(x− h)
2h
(4.15)
The idea behind Richardson extrapolation is that if the function F is well behaved as
h→ 0 and have computed the value of F for two dierent values of h then a good estimate
of F (0) can be computed. From the expression for the truncation error 4.14, it can be
generalized that the truncation error between two arguments h and qh is proportional to
hp, given this Richardson extrapolation denition as quoted from Elden et al. [22] is:
Denition Richardson Extrapolation: If
F (h) = F (0) + chp +O(hr), r < p, (4.16)




(F (h)− F (qh)) = F (0) +O(hr) (4.17)
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Practical Implementation Now we provide the procedure for practical implementation
of Richardson extrapolation. The idea is to perform repeated Richardson extrapolation.
Consider the expansion:
F (h) = F (0) + a1h
p1 + a2h
p2 + ..... (4.18)
Now, let us assume that we know the exponents p1, p2, ....., but a1, a2, ...... are unknown.
Finally, we assume that F has been computed for arguments ....q3h, q2h, qh, h.
Next, let F1(h) = F (h), then we have:
Fk+1(h) = Fk(h) +
1
qpk − 1
(Fk(h)− Fk(qh)) k = 1, 2, ... (4.19)
Now, eliminate the hpk-term from the expansion we get.
Fk+1(h) = F (0) + ˜ak+1h
pk+1 + ˜ak+2h
pk+2 + .... (4.20)







F1(h) F2(h) F3(h) F4(h)
... . . . . . .
... . . .
. . .
Using this arrangement the values of function are calculated row by row and extrapolations
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are done till consecutive values in the same column achieves desired accuracy. This rear-
rangement has advantage that dierence between two adjacent values of the same columns
provides an upper bound for the truncation error provided h is very small. In practice
values of p and q are determined through experiments.
Conclusion Numerical approximations of derivatives are good substitutes for exact deriva-
tives, which may not be available in many cases. We used forward dierence approxima-
tion to estimate the local sensitivity coecients which was further checked for accuracy
using the Richardson extrapolation method. We used the MATLAB® implementation of
Richardson extrapolation provided by Elden et al. [22].
4.2.2 Automatic Dierentiation (AD)
In AD the function is broken down into the composition of elementary arithmetic operations
to which the chain rule (dierentiation chain rule) can be applied. AD has two basic modes
of operations, the forward mode and the reverse mode. In the forward mode the derivatives
are propagated throughout the computation using chain rule. The reverse mode computes
the derivatives for all variables backwards (i.e. reverse order) through the computation.
The reverse mode requires saving the entire computation trace since the propagation is
done backwards through the computation. Hence the reverse mode can be prohibitive for
certain problems due to memory requirements.
Jacobian Calculation The m × n Jacobian matrix of function f : Rn → Rm can be
evaluated in forward mode by n sweeps of forward accumulation, such that each sweep
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yields a column vector of the Jacobian matrix. Alternatively, in the reverse mode, m
sweeps are needed; each sweep yields a row vector of the Jacobian.
AD and nite dierence Next we compare the key dierence between automatic dier-
entiation and nite dierences. The most signicant advantage of AD is that it computes
the derivatives exactly up to machine precision whereas nite dierences incur truncation
errors. Furthermore, the accuracy of nite dierence depends on the step-size, which in
many problem settings is dicult to best determine. In AD there is no need for selecting
step size. It is important to note that if the function computation itself is not accurate
(e.g. if the function evaluation incurs round-o errors), then these errors will appear in
the AD process as well.
AD is also traditionally faster than nite dierence since AD can take advantage of the
problem structure. For the discussion on this topic see Griewank [27].
Current Limitations Although, automatic dierentiation has proved to be useful tech-
nique for calculating accurate derivatives, its application is limited. For example, the
evaluation of functions that depends on oating point arithmetic will involve truncation
error τ . That is we have f̂(x) = f(x) + τ(x), where ˆf(·) is the computed value of f(·) and
τ(·) is the truncation error. Although, |τ(x)| is small, its derivative τ ′(x) might not be
small quantity, so the error in the computed derivative f̂ ′(x) might be large. Error can also
arise in the way the function evaluation is implemented in the automatic dierentiation
code. A frequent practice is to have branching in the code to improve the speed or accu-
racy of function evaluations in certain domains. For further discussion and an approach to
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dealing with this issue readers can check into Griewank [27].
We conclude that automatic dierentiation is a useful technique and can be used to
solve many practical problems. Automatic dierentiation facilitates interpretations of the
computed optimal solutions, allowing the modeler to extract more information from the
results of the computation. However, care should be taken while calculating derivatives as
automatic dierentiation has certain limitations.
4.2.3 Symbolic Dierentiation
Symbolic dierentiation involves the technique of computer algebra. In this method, a
function f is decomposed into algebraic specication which is then manipulated by sym-
bolic manipulation tools to produce a new algebraic expression for each component of the
function gradient. A detailed discussion on the topic is beyond the scope of the present
work; for more details, readers are referred to Pavelle et al. [84]. There are many packages
available for symbolic computation, e.g. Mathematica, Maple, Mupad and many more.
We used the MATLAB® symbolic computation tool (Mupad) implemented in SBTOOL-
BOX2 [97] to calculate the symbolic Jacobian of our ODE system. The use of the symbolic
jacobian makes the ODE solver highly ecient, but care should be taken in using the
expression since for certain values the expression might lead to a computer arithmetic
problem. Especially, in the case of kinetic models, certain ux expressions might lead to
NAN for certain initial conditions or parameter combinations.
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4.3 Global Sensitivity Analysis (GSA): Introduction to
PRCC, eFAST and Sobol's method
As discussed in chapter 3 section 3.4 GSA is an analysis method for exploring the eect
of uncertainty in the parameters values. In this section we discuss three GSA methods:
PRCC, eFAST method and Sobol's method. The basic assumption is that each input
parameter is viewed as a random variable, with an associated probability density function
(PDF) and a cumulative density function (CDF). These methods explore the eect of
parameter variations on the model output. That is, they determine which parameters
produce maximum variance in the output (4.3). The general procedure of the GSA method
involves: assignment of a PDF to each input parameter, sample generation through a
selected sampling method in the parameter space, evaluation of model output on each
sample point, and nally a method to dene the sensitivity measure.
4.3.1 Sampling Methods
For illustration let us consider a single output model dened as:
y = f(p) (4.21)
where p = (p1, ....pN) is the input parameter, with each coecient assumed to lie in interval
pi ∈ [αi, γi]. The output function is then evaluated on M samples generated from a selected
PDF. The construction of appropriate sample is signicant in determining the output's
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Figure 4.3: Schematic illustration of global sensitivity analysis (GSA). While local sen-
sitivity analysis (LSA) is restricted the point at which analysis is done, a GSA measure
scans the entire parameter space.
Random Sampling The most common approach is to select uniform random samples
of numbers x in the interval [0, 1]. For the chosen number x, we determine the associated
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sample value pi, in the interval [αi, γi], by nding the inverse of cumulative density function
(CDF) that is p = CDF−1(x). This sampling method has two main advantages: it is easy
to implement, and for large samples, it produces unbiased estimates of the mean and
variance of output y. However, in the case where the sample interval [αi, γi] is subdivided
into a large number of equally sized sub-intervals then we need to take large number of
samples which might be computationally very intensive.
Stratied Sampling A more elaborate sampling strategy is stratied sampling. In this
method rst the input parameter interval is divided into sub-intervals. Then, a random
sample is chosen from each of the sub-intervals. The idea behind stratied sampling is to
ensure that we obtain samples from each particular interval.
Latin Hyper-cube Sampling (LHS) is another commonly used stratied sampling method.
LHS sampling can be viewed as a square with M equally divided rows and columns such
that in each row and column one and only one cell is occupied. The motivation behind
this strategy is to replace the concept of a particular cell being occupied with getting a
sample from the particular associated sub-intervals. Further constraints are imposed on
the sampling so that the distributions of samples will be evenly distributed from the sample
sub-spaces.
Latin hyper-cube sampling is slightly easier to implement compared to other types of
stratied sampling like orthogonal sampling. LHS methods return a sample that gives a
good representation of variability, as well as reduces the variance in the output's evaluation.
The signicant advantage of using LHS is that we can can work with smaller samples sizes
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without a major subsequent loss of quantication of the output's variance.
4.3.2 Regression based GSA Method
Partial Rank Correlation Coecient (PRCC) analysis with Latin hyper-cube
sampling The method of PRCC is useful for the nonlinear models where the relation-
ship between input and output appears to be monotonic [19]. The input data is ranked
in increasing order and the associated output is rearranged accordingly. Next, regression
analysis on the ranked data is carried out to calculate the Pearson rank coecients. Hence,
these measures produce a sensitivity measure of how strong a correlation there is in the
monotonicity between input and output. It is important to note that the method assumes
that the input variables are independent of each other, i.e. the parameters are not corre-
lated. Attention needs to be given to this assumption, otherwise erroneous results will be
produced.
For software implementation we used the PRCC implemented in SBTOOLBOX2 [97].
The implementation uses the Pearson correlation coecient measurement as described by
Blower and Dowlatabadi [5]. The LHS sampling method was used as explained in the
Mckay et al. [69]. The calculated sensitivity measures, which range between [−1, 1], can
be compared among dierent parameters.
4.3.3 Variance-Based GSA method
The limitations of PRCC can be overcome by using model-independent GSA methods.
Variance-based GSA method are suitable for model-independent calculation of sensitivity
91
measures and are well established in the analysis community [93]. Variance based methods
are useful for the following model analysis [93]:
 Parameter Prioritization: identifying parameters which will lead to maximum output
variation.
 Parameter Fixing: identifying parameter variation range in which output variance
will not vary beyond set threshold.
 Variance Cutting: identifying a set of parameters to reduce output variance below a
certain threshold.
 Parameter Mapping: identication of parameter range for which desired output can
be realized.
We used Sobol's method and eFAST for GSA which we describe next.
Sobol's Method In Sobol's method [42], the model output function y = f(p) is decom-
posed into a unique sum of orthogonal functions of increasing dimension. The decomposi-












Dij + · · ·+D1,2,··· ,m (4.23)
where m is the number of parameters, D is the overall variance of the model output, and
Di1....is(1 ≤ i1....is ≤ m) denotes the partial variance contributed by parameter combination
92








where Dtoti is the total variance due to i
th parameter.
For example, consider a single output, two input function:
y = f(p1, p2)
Then this function can be decomposed into orthogonal components:
y = F (p1) + F (p2) + F (p1, p2)
Then variance according to Sobol's method can be estimated as:
D = D1 +D2 +D1,2








Next, the total sensitivity index for p1 is dened as,





Similarly, the total sensitivity index for p2 is dened as,





The signicant computational challenge in Sobol's method is estimating the integral
in 4.22, which Sobol [42] suggested to be estimated by Monte Carlo integration of the
output functions on the random sampling basis. Sensitivity measure are then dened
based upon the fraction of related partial variances in the overall variances. First order
sensitivity measure indicates the impact of individual parameters on the model output,
whereas the total eect sensitivity measure describes the eect of parameter interactions
on the model output.
Interpreting Sobol's Sensitivity Index Let Si be rst order index and Sti be total
sensitivity index.
 Si indicates by how much one could reduce, on average, the output variance if input
parameter pi could be xed. Hence it is a measure of main eect of the parameter.
 Si1...is indicates how much the output variance could be reduced, on average, if one
could x pi1 ......pis . Sti ≥ Si if parameter pi is not involved in any other interactions.
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 Sti−Si is a measure of how much parameter pi is involved in interactions with other
input parameters. Sti ' 0 implies pi is non inuential. 1 −
∑
i
Si is an indicator of
the presence of interactions in the model.
eFAST The eFAST method developed by Saltelli et al. [92], which is an extension of
the Fourier Amplitude Sensitivity Test (FAST) [15], has the advantage that it is possible
to calculate total sensitivity measures in addition to rst order sensitivity measure. In
the eFAST method each uncertain input parameter p̂i is sampled along curves dened by
transformation 4.24 in the normalized unit m-dimensional parameter space, where m is








where each parameter varies periodically at an angular frequency ωi and random phase
shift ϕi, with a scalar variable s ∈ (−π, π). Using this transformation 4.24, the model
output function is expressed as a Fourier series with respect to s. Then, the properties
of Fourier expansion can be applied, by which the overall variance of the output function
D is decomposed into the square of Fourier series coecients. Finally, using Monte Carlo
integration on the sampled parameter space, these Fourier series coecients are estimated,
based on which the eFAST sensitivity measures are dened. A detailed discussion on the
implementation method of eFAST can be found in Saltelli et al. [93]. The interpretations
of the measure are the same as discussed previously for Sobol's method.
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Interpreting Sensitivity Measure The interpretations of variance based sensitivity
measure is same as illustrated in the example 4.3.3. Only the method of estimating the
rst order and total eect sensitivity measure diers between Sobol's method and eFAST.
The PRCC sensitivity measure can be considered equivalent to total eect sensitivity
measure of variance based method [93] provided the assumptions of PRCC holds for the
model output (monotonicity relationship between input and output).
Implementation of the Variance Methods Both Sobol's method and the eFAST
method are implemented in the SBTOOLBOX2 [97]. The toolbox implementation is based
on the discussion of Zhang and Rundell [118]. For our model analysis, we calculated both
the rst order sensitivity measures and total eect measures. Details of our GSA analysis
are documented in the appendix A.2.3. The sensitivity measures are analyzed in chapter
5.
Implementation of the Variance Methods Both the variance based methods are
implemented in the SBTOOLBOX2 [97] and toolbox implementation is based on the dis-
cussion of Zhang and Rundell [118]. We calculated both the rst order sensitivity measure
and total eect measure. The details of GSA simulation is documented in appendix A.2.3
and the sensitivity measures are analyzed in chapter 5.
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4.4 Dynamic Numerical Optimization using Surrogate
Models
Parameter identication in large scale kinetic models is not trivial. The standard opti-
mization procedure of parameter identication (described in Section 4.1) does not return,
in many cases, the required solution. These optimization processes are inuenced by many
factors apart from quality of data, such as the choice of parameters and stability of ODE
solvers. In addition, while the choice of parameters to be t is often identied through
sensitivity analysis, their degree of inuence might vary during the optimization process,
potentially causing the optimization algorithm to fall into the wrong local minimum. Fur-
thermore, many times the system is undetermined, especially if parameter identication
is based solely on steady state data. These shortcomings led us to explore alternative
methods for parameter identication of the kinetic models.
In engineering there is a frequent practice to use a surrogate modeling framework to
optimize functions whose evaluation is computationally expensive. In this surrogate mod-
eling framework we look for a surrogate function sm(x) of true function f(x), such that
sm(x) is simpler to evaluate but reproduces the behavior of the true function f(x). Next,
we optimize over sm(x) instead of f(x) with the constraint that sm(x) is able to faithfully




subject to x ∈ B ≡ {x|a ≤ x ≤ b},
If the cost function shows any of these behaviors: evaluation of f(x) is very expensive,
evaluation of derivative is impossible or costly, evaluation of f(x) is not possible by the
x returned by optimization algorithm (like in case where, to evaluate f(x) ODE needs
to be solved), or evaluation of f(x) returns few correct digits, then in any of these cases
surrogate modeling framework can prove useful for optimization of cost function [6].
Surrogate models are of two types: physical surrogate models and functional surrogate
models. Physical surrogate models are built from physical or numerical simplication
of the true functions. Physical surrogate models are based on some knowledge of the
physical system or phenomena being modeled. So, physical surrogate models are problem-
dependent. However, there are some rigorous methods that have been developed to build
physical surrogate models, such as the space mapping [4] method, which uses the gradient
information of the true function f(x) to build a simplied surrogate model.
Since all the kinetic models follow from a xed set of physical laws, building a physical
surrogate model holds signicant potential. We are exploring the options of space mapping
method for building surrogate models.
Functional Surrogate model Functional surrogate models are algebraic representa-
tions of the true problem functions. In general, functional models are based on the follow-
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ing components: a class of basis functions, a procedure for sampling the true functions,
a regression or tting criteria, and some deterministic or mathematical technique to com-
bine them all. It is important to note that functional surrogate models are mathematical
in nature dierent from true, original functions. However, the coecients of the func-
tional model are tuned to reproduce the behavior of the true function f(x). This has
the signicant advantage that functional surrogate models are generic and empirical and
not restricted to certain classes of problems as physical surrogate models are. Functional
surrogate models are strongly dependent on samples of the true function.
Among many available methods for building functional surrogate models: radial basis
functions and Kriging models [91] are popular choices. We have used the DACE tool-
box [106] to build functional surrogate models based on the Kriging approximation. For a
detail discussion on surrogate models readers are directed to the book by Conn et al. [12].
In this section we briey discussed the possible problems in parameter identication
of the kinetic model and possible solutions. We are actively pursuing the idea to build a




Model of Pyruvate Recycling Pathways
In this chapter we describe our model of pyruvate recycling in β-cells, and use the model
to draw insights into system behaviour.
5.1 Model Description
The ordinary dierential equation (ODE)-based model describes the kinetics of 30 enzyme-
catalyzed reactions in β-cell metabolism (Figure 5.1). The model state variables are the
dynamically independent concentrations of 24 metabolite species in two compartments
mitochondrial matrix and the cytosol (the mitochondrial inter-membrane space is ne-
glected). One additional species concentration is determined through conservation. The
concentrations of seventeen additional species are held constant as model parameters. De-




































































Figure 5.1: Pyruvate recycling in β-cells. Pyruvate is converted to oxaloacetate by PCm.
Oxaloacetate is converted to citrate and isocitrate, both of which are transported between the cy-
tosol and the mitochondrial matrix. Citrate is converted into isocitrate by ACOc. Isocitrate can be
converted to α-ketoglutarate (αKG) via ICDc. Isocitrate is then converted into αKG through ICDc
then αKG may enter the mitochondria for conversion to malate by TCA cycle enzymes, and subse-
quent conversion to pyruvate by MEm or MEc, thus completing the pyruvate cycle. Abbreviations. In-
ux model: GLC:Glucose, F6P:Fructose-6-phosphate, FBP:Fructose-1,6-bisphosphate, GAP:Glyceraldehyde 3-phosphate, DPG:1,3-bisphospho-
D-glycerate, PEP:Phosphenol Pyruvate, GT:Glucose Transporter, GK:Glucokinase, PFK:6-phosphofructokinase, FBA:fructose-bisphosphate
aldolase, GAPD:glyceraldehyde 3-phosphate dehydrogenase, PGP: bisphosphoglycerate phosphatase, PK:Pyruvate kinase, LDHc:Lactate de-
hydrogenase, ACOm:Aconitase Mitochondrial, ACOc:Aconitase Cytosolic, CIC:Citrate Carrier, DIC:Dicarboxyrate Carrier, CLc:Citrate Lyase
Cytosolic, CSm:Citrate Synthase, FMm:Fumarase, IDHm:Isocitrate Dehydrogenase Mitochondrial, IDHc:Isocitrate Dehydrogenase (NADP+)
Cytosolic, MDHm: Malate Dehydrogenase Mitochondrial MDHc: Malate Dehydrogenase Cytosolic, OGC:Oxoglutarate Carrier, PCm:Pyruvate
Carboxylase PDCm:Pyruvate Dehydrogenase Complex, PYC:Pyruvate Carrier, AKDm:α-Ketoglutarate Dehydrogenase, SCS:Succinyl-CoA syn-
thetase, SDHm:Succinate Dehydrogenase, MEm:Malic Enzyme Mitochondrial, MEc:Malic Enzyme Cytosolic.
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The network input is extra-cellular glucose, which enters the cytosol via the high-
capacity, low-anity glucose transporter-2 (GLUT2). This transport step is modeled as
previously reported by Sweet and Matschinsky [108]. Glucose is converted to pyruvate by
the six-step glycolysis pathway [47]. The kinetics of all glycolytic reactions were drawn
from the SABIO-RK database [112], with some adjustments (details in the Appendix A.1).
The glycolytic pathway is treated as a xed inux module, and is not included in the
subsequent model analysis (Section 5.3). The end-product of glycolysis, cytosolic pyruvate,
is either converted to lactate (by lactate dehydrogenase (LDH)) or transported into the
mitochondrial matrix. (The former process carries much less ux than the latter; LDH
activity is weak in β-cells [110].) The TCA cycle operates within the mitochondrial matrix.
All components of the three pyruvate recycling processesthe pyruvate/malate cycle, the
pyruvate/citrate cycle, and the pyruvate/isocitrate cycleare included in the model.
Simulation Method The system was simulated using mass conservation laws for each
of the dynamically independent species. The reaction kinetics and model equations are
included in the Appendix A.1.4. Simulations were carried out in MATLAB (function
ode15s). Models steady-state concentrations is conrmed by the application of Trust-
region-dogleg method to the long-time simulation outputs (MATLAB function fsolve).
The details of simulations are provided in Appendix A.2.1.
Parameterization Approach The reaction kinetics, as well as the bulk of the param-
eters, were derived from the previous models of Yugi and Tomita [116] and Westermark
et al. [110]. After formulating the model, we performed a preliminary global sensitivity
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analysis to identify parameters that could be adjusted to provide better ts to recent data.
We selected parameters whose values are not well-characterized and that had a signicant
contribution to the overall sensitivity, but did not impact the crucial measures of (i) the
ratio of metabolic to cytosolic malice enzyme activity, and (ii) the ratio of pyruvate dehy-
drogenase to pyruvate carboxylase activity. We arrived at a set of 34 model parameters to
be t. Fixing the values of the other 89 parameters as found in the literature, we calibrated
the values of the 34 adjustable parameters by tting to the experimental observations of
Ronnebaum et al. [88]. That paper provided 32 steady state metabolite concentration
measurements (8 species in 4 conditions) against which to t the model. This data will be
referred to as the training set. Parameter values were estimated using the simplexSB and
simannealSB algorithm provided by SBTOOLBOX2 software package [97]. The param-
eters values were identied by minimizing least-squares error, weighted by variability in
the data. Details of the calibration routine, including the bounds used for the parameter
search, are presented in the Appendix A.2.2.
Having found a best-t to the training set, we then veried the model by comparing
model predictions against a range of experimental results on β-cells metabolism [49, 50,




The model was parameterized against a training set provided by the experiments (gene
knock-down via short interfering RNA (siRNA)) in Ronnebaum et.al. [88], in which siRNAs
specic for the mRNA of the ICDc enzyme were used to reduce the activity of ICDc. To
simulate the eect of the siRNA treatment, we reduced the Vmax parameter of ICDc by the
measured decrease in enzyme activity (39.1%). Ronnebaum et al. collected steady-state
metabolite measurements of eight metabolites in each of four cases: control and knock-
down at low glucose (3mM) and high glucose (12mM). Simulating these cases to steady
state, we calibrated the model by minimizing a least-squares measure of error. The best-t
model behavior is shown in Figure 5.2. The best-t model parameters are reported in the
Appendix A.3, along with the values of the 89 parameters that were taken directly from
the literature.
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Figure 5.2: Best-t model tting to data from Ronnebaum et.al. experiments. Panel
A. Low glucose, control. Panel B. High glucose, control. Panel C. Low glucose, ICDc


























































































































Figure 5.3: Simulation Comparison with Observed values for NADPH Ronnebaum et.al.
data. 5.3a 3mM glucose input control case. 5.3b 3mM glucose input knock down case. 5.3c
12mM glucose input control case. 5.3d 12mM glucose input Knock down case.
5.2.2 Model Testing
To validate the model we compared model predictions against a test data set gathered
from the literature. (None of this test-set data was used in parameter tting.)
106
Lactate Dehydrogenase Activity We found that the model corroborates the experi-
mental observation by Sekine et al. [101] that, in comparison with other cell types, β-cells
exhibit signicantly reduced lactate dehydrogenase (LDH) activity. In the model network,
glucose-derived pyruvate is either converted to lactate by LDH or is transported into the
mitochondria by the pyruvate transporter (PYC). We compared the ux through these re-
actions over a wide range of glucose levels (2.5mM to 22mM) and found that LDH exhibits
between 2-4% of the PYC ux.
Malic Enzyme Activity It has been shown that in β-cells, the cytosolic form of malic
enzyme (MEc) contributes approximately 90% of the total malic enzyme activity in the
cell, at glucose concentrations ranging from 3mM to 20mM [32]. Simulations of the model
predict that roughly 95% of malic enzyme ux is carried by MEc, for glucose levels ranging
between 2.5mM and 22mM.
Pyruvate Carboxylase Activity Radio-isotopic experiments have revealed that in β-
cells approximately 40% of glucose-derived pyruvate enters the TCA cycle via PC-catalyzed
conversion to OAA, with the remainder metabolized to acetyl-CoA via pyruvate dehydroge-
nase (PDH) [57, 100, 67, 65]. The model predicts that over the range of 12-20mM glucose,
approximately 40% of pyruvate enters the TCA cycle through pyruvate carboxylase. This
percentage increases to above 50% at low glucose (3mM).
Pyruvate Recycling Using a 13C NMR isotopomer method, Lu et al. [63] measured
the rate of pyruvate recycling, which they dened as the ratio of PC ux to the overall
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TCA cycle ux. This study was carried out in a set of clonal cell lines derived from
rat insulinoma INS-1 cell lines; these cells exhibit a broad range of GSIS sensitivity and
are thus useful for investigating the amplifying pathway response. They found that the
anapleurotic ux catalyzed by PCm is correlated with GSIS, while pyruvate dehydrogenase
(PDHm)-mediated entry of pyruvate into the TCA cycle is not signicantly aected by
changes in glucose abundance. Their results are shown in gure 5.4a, along with the model
predictions. While the model underestimates the recycling rate, it correctly captures the
increase in recycling rate with glucose availability. The experiments of Lu et al. revealed
that the acetyl-CoA does not increase linearly with glucose availability, but saturates by
about 13.5mM glucose concentration. Figure 5.4b shows our model predictions of this
saturation trend.















































Figure 5.4: 5.4a Simulation result of pyruvate recycling at dierent glucose level. The
comparison is done against glucose responsive cell lines 5.4b Percentage increase in Acetyl-
CoA as glucose concentration is increased showing saturation.
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Ronnebaum et al. made measurements of the pyruvate recycling rate in wild-type and
ICDc knock-down strains. We calculated the pyruvate recycling ratio from model simula-
tion. We found that at 3mM glucose for the control case the ratio is .3483 while for ICDc
knock down it is .1498 (at 12mM glucose simulation there is little variation in the ratio;
control case is .3485 and ICDc knock down is .1499). This data shows the eect of the
ICDc knock-down on pyruvate recycling.
ATP Citrate Lyase Knockdown Joseph et al. [52] conducted siRNA-mediated sup-
pression of citrate lyase (CL). They estimated that CL activity was reduced by 75±4%; this
resulted in a 52± 7% reduction in cytosolic oxaloacetate, and no signicant impact on the
NADP:NADPH ratio (steady state, at 16.7mM glucose). We simulated this experiment by
reducing the V max value for CL by 75%. At steady state, for 16.7mM glucose, the resulting
change in the NADP:NADPH ratio is .01%; the cytosolic oxaloacetate concentration drops
by 62.8%. (The model predicts a more modest drop in OAAc at lower glucose levels, e.g.
54.4% at 3mM).
Pyruvate Carboxylase Knock Down Jensen et al. [46] conducted an siRNA-mediated
knock-down of pyruvate carboxylase. In their knock-down strain, PC activity was reduced
by 65%, but there was a minimal eect on the glucose-dependence of the NADPH:NADP
ratio (Figure 5.5c). The model predictions conrm that a 65% decrease in PC activity
(i.e. in the corresponding Vmax parameter) has a negligible eect on this glucose-dependence.
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AdsiControl to AdsiPC, 2.5mM glucose
AdsiControl to AdsiPC, 12mM glucose
(d)
Figure 5.5: Low Glucose 2.5mM, High Glucose 12mM 5.5a Comparison of Pyruvate Recy-
cling for the case of PC knock down. 5.5b Concentration trends of metabolites for PC knock
down. 5.5c No eect on NADPH:NADP ratio due to PC knock down. 5.5d Comparison
between simulation and eect of PC knock down on metabolites and uxes.
Jensen et al. also analyzed the eect of their PC knockdown on the concentrations
of TCA cycle intermediates. In the control case, they found that the concentrations of
succinate, malate, α-KG and citrate increased 2-30 fold when glucose was increased from
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2.5mM to 12mM (Figure 5.5b). When PC activity was suppressed no changes were observed
in the glucose-response of succinate, fumarate and malate; however, the glucose-response
of α-KG was signicantly reduced (Figure 5.5b). The model successfully predicts these
eects (Figure 5.5b, 5.5d). Figure 5.5d shows that the model captures the eect of PC
suppression on acetyl-CoA and lactate that is increment in there concentration when PC
is suppressed compared to control case.
Malic Enzyme Cytosolic Knock Down To investigate the role of the pyruvate/malate
cycle, Ronnebaum et al. [89] conducted siRNA-mediate knock-down experiment of cytosolic
and mitochondrial malic enzyme. They found that knock-downs of either enzymes by 75%
had no eect on the pyruvate recycling rate at either 2.5mM or 12mM glucose. Figure5.6a
shows the data along with model prediction for cytosolic malic enzyme, the result for
mitochondrial malic enzyme is similar. Actually there is nothing to compare relevant to
model and all the study is done using MEc knock down. However, their experiments showed
that the NADPH concentration was reduced by the MEc knock-down . We simulated these
experiments by reducing the Vmax of MEc by 75%. The simulation results are shown in
Figure 5.6.
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Figure 5.6: Low Glucose 2.5mM, High Glucose 12 mM. 5.6a Eect of MEc knock down on
Pyruvate Recycling. 5.6b Eect of MEc knock down on NADPH concentration.
Aryl Hydrocarbon Knock Down Pillai et al. [85] investigated the metabolic eect
of an siRNA-mediated knock-down of the transcription factor aryl hydrocarbon receptor
nuclear translocator (ARNT)/hypoxia-inducible factor (HIF)-1β, which regulates expres-
sion of ICDc, MEc, CL, PC, AKD, CIC, and DIC. In their experiments, they found that
a knock-down of ARNT down-regulates glycolysis, anaplerosis and glucose-induced fatty
acid production, all of which are known to be important events in GSIS. Pillai et al. mea-
sured the steady-state concentrations of several TCA intermediates at both low and high
glucose levels, in the control and knock-down cases (Figure 5.7). The control cases are
directly comparable with the control cases from our training data (from Ronnebaum et
al. [88]).
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Figure 5.7: Simulation Comparison with Observed values for Pillai et.al. data (not
scaled). 5.7a The model simulation is compared to 2.8mM glucose input with the Pil-
lai et.al. data for the control case. 5.7b The model simulation is compared to 16.7mM
glucose input with the Pillai et.al. data for the control case. 5.7c The model simulation
is compared to 2.8mM glucose input with the Ronnebaum et.al. data for ARNT1 Knock
down case. 5.7d The model simulation is compared to 16.7mM glucose input with the
Pillai et.al. data for ARNT1 Knock down case.
However, because these experiments were carried out in dierent conditions, the quan-
titative measurements are not entirely consistent. In order to arrive at a prediction that is
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consistent with the training set, we introduced a set of scaling factors. The scaling factor
is decided by scaling the Pillai et al. [85] low glucose control data to that of Ronnebaum
et al. [88] low glucose control data. We added a correction factor by measuring the fold
increase of metabolite in model simulation when glucose is raised from 2.8mM to 3mM
and for high glucose 12mM to 16.7mM since the Pillai et al. [85] experiments are done
at this glucose concentration. Pillai et al. Pillai et al. report that their siRNA results
in the following decreases in enzyme activity: ICDc: 89.29%, MEc:54.76%, CLc:54.17%,
PCm:46.43%, AKDm:63.10%, CIC:94.05% and DIC:60.71%. Simulation of the model with
the corresponding decreases in Vmax values are compared with the experimental ndings in
Figure 5.7.
Model Trends of NADPH concentration prole In addition to the measurements of
NADPH concentration reproduced in gure 5.3, Ronnebaum et al. [88] also made measure-
ments of the NADPH/NADP ratio at a range of glucose concentrations. The model accu-
rately predicts these ndings, as follows. Ronnebaum et al. found that the NADPH/NADP
ratio increases by 33.33% when the glucose concentration is increased from 3mM to 4mM;
the model simulation shows an increase of 49.00%. The experiments showed that the ratio
increased 35.71% when glucose was increased from 4mM to 6mM; simulation predicts a
64.25% increase. Finally, Ronnebaum et al. report a 50% increase in the NADPH/NADP
ratio when glucose was increased from 6mM to 12mM; simulation of this comparison pre-
dicts a 95.12% increase in the ratio. When compared to siICDc knock down we found that
NADPH/NADP ratio decreases by approximately 42% at 3mM while simulation shows de-
crease of .0013%, similarly at 12mM glucose observed decrease is 17.11% while simulation
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is .00032% (Figure 5.8a).
Table 5.1: NADPH percentage increase in concentration when glucose concentration is
raised
Glucose increment (mM) Observed Simulation
3 to 4 3.33e+01 4.90e+01
4 to 6 3.57e+01 6.42e+01
6 to 12 5.00e+01 9.51e+01
3 to 12 1.25e+02 5.80e+02
Sener et.al. [103] hypothesized that the NADPH:NADP ratio can be inferred from the
pyruvate:malate ratio or the citrate:α-KG ratio. Our model prediction of this result, which
is consistent with this prediction, is shown in gure 5.8a.
Finally, Hedeskov et.al. [33] found that the NADPH/NADP ratio increases 125% when
glucose is increased from 3mM to 20mM. The model predicts an increase of 71.461%.

























































Figure 5.8: 5.8a Comparison between simulation and observed percentage increase in




To identify important control points in the pathway we performed local sensitivity and
global sensitivity analysis. These analyses were carried out as described in sections 3.3,
3.4, 4.3.
Properties of Sensitivity Measure Variance-based GSA methods allow us to calcu-
late both rst-order and total-eect sensitivity rankings. First-order sensitivity reects the
eect of variations in single parameters on the model output, whereas total-eect sensi-
tivity describes the dependence of the model output on the parameters in combination.
Comparisons between the rst-order and total-eect sensitivity predictions can provide
insight into interactions among parameters.
For Sobol's method we only report the total eect measure, since the rst order eect
measures have many negative values. The design of Sobol's method allows to have neg-
ative values but comparison with eFAST is not possible as eFAST method design allows
only positive values. The complete discussion on this topic can be found elsewhere [93].
Therefore, all the comparison between eFAST and Sobol's method will be done for total
eect measure. To identify the interaction among parameters, eFAST rankings of rst
order eect and total eect measure will be used.
As a generic model output, we consider overall output as the sum of the squared
deviation in all metabolite levels (See appendix for details A.2.3). Parameters that show
the largest sensitivity rankings with respect to this over all measure (by either the rst-
order or total-eect approach) are the most inuential in setting model behavior. The
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overall sensitivity rankings provided by for Sobol's method and the eFAST method were
found to be consistent (A.4.1).
5.3.1 Sensitivity Results
GSA Measure with respect to steady state cytosolic pyruvate and NADPH
Figures 5.9 and 5.10 show the ranked sensitivities with respect to two model outputs: the
steady-state concentration of cytosolic pyruvate and the steady-state NADPH concentra-
tion.
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Figure 5.9: Global sensitivity ranking with respect to cytosolic pyruvate. Panel A eFAST
total eect, Panel B eFAST rst order, Panel C Sobol's total eect and Panel D PRCC.
For parameters description refer to Tables A.8,A.7 and A.6
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Figure 5.10: Global sensitivity ranking with respect to NADPH. Panel A eFAST total
eect, Panel B eFAST rst order, Panel C Sobol's total eect and Panel D PRCC. For
parameters description refer to Tables A.8,A.7 and A.6
Local Sensitivity of cytosolic Pyruvate and NADPH The top ten sensitivity co-
ecients for cytosolic pyruvate and NADPH are shown in gure 5.11.
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Figure 5.11: Local sensitivity parameter ranking with respect to cytosolic pyruvate and
NADPH. Panel A cytosolic pyruvate and Panel B NADPH. For parameters description
refer to Tables A.8,A.7 and A.6
Eect of Pyruvate Carboxylase In order to understand the eect of perturbations
in the concentration of pyruvate carboxylase (PC) on the pyruvate recycle pathways; the
sensitivity measures have been reformulated such that ranking of uxes are done based on
the eect caused by the perturbation in PC. Figure 5.12 shows the degree of eect of PC
Vmax on dierent uxes of the pathway. The ranking shows the ve most aected uxes
and the ve least aected uxes.
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Figure 5.12: Eect of perturbation of PC, Vmax on uxes. Five most sensitive uxes and
ve least sensitive uxes are plotted . Panel A: local sensitivity. Panel B: PRCC ranking,
Panel c: eFAST total eect and Panel D: eFAST rst order. Sobol's total eect ranking
is same as that of eFAST total eect ranking. For ux description refer to Tables A.8,A.7
and A.6
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5.3.2 Analysis of Pathway Properties
Given the highly non-linear nature of the model, it is valuable to compare results of dierent
sensitivity analyses in order to gain insight of model behavior. By comparing dierent GSA
rankings and local sensitivity coecients, we can identify important regulatory properties
of the metabolic pathway.
Analyzing the rst-order and second-order overall sensitivity rankings reveals that the
Vmax of LDH is the most inuential parameter in the model. However, comparison between
the rst and second order rankings reveals that the Vmax's of fumarase, DIC and MDHm
are the most signicant in terms of interactions among all model parameters. These three
enzymes are known to be important participants in pyruvate recycling pathways.
Next we consider the GSA sensitivity index for the model output of steady state cy-
tosolic PYR concentration. The analysis of sensitivity of PYR reveals that the Vmax's of
pyruvate transporter (PYC) and citrate synthase (CSm) are the most inuential param-
eter (in terms of both rst-order and total-eect). This implies that PYC and CSm has
a dominant eect on the PYR concentration, regardless of perturbations to the rest of
pathway. However, the comparison between rst-order and total-eect sensitivities reects
important variance in ranking for other model parameters.
Considering the sensitivities with respect to both PYR and steady-state ICDc ux A.4.2
(the latter of which is the main produced of NADPH), we nd that, consistent with the
result that the Vmax of CIC, DIC, PC and MEc have the most inuence over parameter
interactions, their rst-order rankings are low, while the total eect rankings are high.
These parameters are thus involved in parameter interactions that inuence PYR and
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ICDc ux.
We next consider the sensitivities with respect to the steady state NADPH level. First
order sensitivity rankings indicate that the NADPH consumption rate (characterized by
v14_1 and v14_2) is the most inuential reaction; this is consistent with the model struc-
ture. Total sensitivity index ranks the Vmax of CIC, DIC, PCm and MEc as, again, the
most inuential parameters.
It is interesting to note that the sensitivity rankings by local sensitivity analysis and
GSA dier. These dierences reveal the extent to which interactions among the param-
eters inuence the model. For example, the Vmax of ICDc enzyme ranked lower in the
local analysis than in the global analysis (with respect to the ICDc ux). This implies
that inuence of the enzyme on ICDc ux is sensitive to the action of other parameters.
However, in the local domain of parameter variation the Vmax of ICDc enzyme is robust to
external perturbations.
Comparison between overall measure sensitivity ranking of total-eect and rst-order
analyses reveals the highly interacting parameters. We found that the Vmax of LDH, MDHc,
MDHm and fumarase are the most highly interacting parameters of the model. These
parameters are fairly non-inuential individually but combined with other parameters exert
signicant inuence on the model output.
Comparison of the local sensitivity rankings (5.12) of PC Vmax perturbation with the re-
spective global sensitivity rankings reveals that MEc and ICDc are robust to perturbations
to PC, at least locally. This is consistent with the observation that the PC knockdown
did not aected the NADPH:NADP ratio nor the pyruvate recycling ratio (section 2.5).
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However, the global sensitivity results show active interactions. The PRCC ranking is
dierent from eFAST total eect, implying loss of monotonicity of the input-output rela-
tions. Signicantly, the dierence in ranking of eFAST rst-order eect and total-eect
ranking imply strong impact of PC on the pyruvate uxes due to interactions in the path-
way. The impact on lactate dehydrogenase ux is maximum in the total eect ranking,
providing a reason why lactate concentration goes high in the case of PC knock down
(section 2.5). Comparison in these two rankings reveals that MEc, PYC, and DIC are
robust to PC perturbation, providing a plausible reason why perturbations to PC do not
impact the pyruvate recycling rate. Finally, we note that ICDc ux is not signicantly im-
pacted by the PC perturbation, explaining why NADPH concentrations are not sensitive
to perturbations in PC level.
Based on our comparative analysis, sensitivity ranking of the model predicts that the
Vmaxs of the pyruvate transporter (PYC) and citrate synthase (CSm) have the most signif-
icant impact on the pyruvate recycling rate. However, Vmaxs of PYC and CSm don't show
interaction with other parameters in the pathway. Therefore, perturbations in Vmaxs of
PYC and CSm might lead to loss of robustness of the pyruvate recycling rate. In contrast,
the Vmaxs of transport enzymes citrate isocitrate carrier (CIC) and dicarboxylate carrier
(DIC) exhibit maximum interaction among the remaining parameters of the model. This
interaction can compensate perturbations in the other parameters. Knock-down of CIC
and DIC has been shown to inhibit the glucose stimulated insulin secretion [51] (Section
2.5).
Taking these results together, the model predicts that combined perturbations (e.g,
of both PYC and CIC, or CSm and DIC) can have the double-eect of a signicant and
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robust impact. The model suggest that these combined perturbations show the greatest
promise as drug targets for modulation of the pyruvate recycling rate and NADPH:NADP
ratio (and hence insulin secretion). This proposal could be addresses by experiments that




In the current work we developed a detail model of pyruvate recycling and validated the
model against known results regarding pyruvate recycling components. As described, the
model conrms a number of relevant experimental ndings. We successfully trained the
model to the data from Ronnebaum et al. [88]. Next we successfully tested the model
against observations of β-cells metabolism. Our model reproduces most of the properties
of the GSIS investigation done by 13C istopomer analysis and siRNA mediated knock down
studies.
We performed the local and global sensitivity analysis to identify the important control
points in the pathway. The analysis reveals that the pyruvate level is most inuenced
by the Vmax of PYC and is robust to external perturbation. From within the pyruvate
recycling pathways, the Vmax of DIC, MEc and PCm have the most signicant inuence
over the pyruvate level, indicating that these are important control points in the TCA
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cycle anaplerosis. Similarly NADPH is inuenced most by these parameters, establishing
a further correlation between pyruvate recycling and GSIS.
The current model can serve as a template model for future addition of extra pathways
and an integrated study of triggering signals and the amplifying pathway. By conducting
global sensitivity analysis and local sensitivity analysis we identied the important con-
trol points in the pathway. The model predicts that study of combine gene knock down
experiments of pyruvate transport, and citrate isocitrate carrier (CIC) or citrate synthase
(CSm) and dicarboxylate carrier (DIC) can modulate the behavior of pyruvate recycling
rate and hence will have signicant impact on glucose induced insulin secretion.
We propose that any future extension of the model should be trained with additional
data sets or produce better data t than current model. The possible extensions of the
model are discussed in next section.
6.1 Future Work
Biological modeling oers a powerful approach to decipher the complex regulatory mech-
anisms underlying basic biological processes. At the same time it raises interesting math-
ematical challenges for solving these problems.
Model Extensions In principle, the the β-cells action is very simple to explain: they
sense the glucose levels in the blood and secrete insulin into the bloodstream to maintain
glucose homeostasis. However, to carry out this simple task β-cells use complex regula-
tory mechanisms involving multiple levels of regulation. The experimental data for the
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metabolism in the β-cells show distinct mechanisms of regulation. The model presented in
this study is the rst pyruvate recycling model to be corroborated against the experimental
data in β-cells. However, the model was focused solely on the pyruvate recycling pathway.
The immediate extension of the current model would be to incorporate the dynamics of
ATP, ADP, and Ca2+ molecules and the regulatory eect on the enzymes. These molecules
are known to be allosteric modiers of many enzymes in the insulin pathway. This will
allow the analysis of coupling between the ATP:ADP ratio and the NADPH:NADP ra-
tio, and thus provide an avenue for addressing the correlation between the triggering and
amplifying signals. Another valuable extension would be integration of detailed models of
glycolysis, pyruvate recycle, and TCA cycle pathways. This will allow the study of citrate
feedback on the glycolytic enzyme phosphofructokinase (PFK) (citrate is an inhibitor of
PFK). Moreover, in the current model we did not consider the role of GTP as a potential
metabolic coupling factor. In a future extension of the model, enzymes involved in GTP
generation could be included.
Computational Challenges in Developing Large Scale Kinetic Models One of
the challenges in developing large scale kinetic models is that simulation of the systems of
dierential equations and parameter identication are not trivial. Often ODE solvers fails
to return solution for certain sets of parameters; similarly, optimization algorithms can fail
to return satisfactory solutions. Recent mathematical developments might prove useful in
addressing some of these challenges [9, 78, 44, 90, 74].
Solving kinetic model involves the use of ODE solvers. Most kinetic models are very
sti, with signicant variations in the eigenvalues of the Jacobian matrix. This puts restric-
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tion on the stability and eciency of the sti ODE solvers. Frequently, approximation of
the Jacobian approximated via nite dierence introduces truncation errors. Improvements
in the accuracy of Jacobian approximation can thus lead to a signicant improvement in the
performance of ODE solvers. Symbolic dierentiation is either not always available, or, due
to the complexity of the rate expression, the expression returned through symbolic tools
might have singularities. These limitations can be easily be improved by using automatic
dierentiation (AD) [9]. AD is underused in the kinetic modeling community. It holds
signicant potential for improvements in nding the solutions of ODE. Furthermore, AD
can signicantly improve the eciency of the ODE solver in the Newton iterations (many
sti solvers involve Newton iteration which relies on nite dierence approximation).
Recent improvements in interval arithmetic have led to a new class of ODE solvers
which use interval arithmetic to solve the ODE [90, 74]. The advantage of using these
solvers is that the uniqueness of solution is guaranteed [78, 44]. Testing interval arithmetic
solvers in large scale kinetic model has yet to be done and holds signicant potential.
One of the major challenges in developing large kinetic model is that all the kinetic
data is not readily available. As a result parameters are empirically identied in order
to successfully reproduce the experimental results. Since this scenario is unavoidable for
large scale kinetic model, developing rigorous surrogate optimization frameworks will lead
to a signicant improvement in the identication process [6]. Attempts have been made to
build simplied representations of ODE systems using spline approximation [117]. Using
surrogate models to replace expensive function evaluations has been found to be a pow-
erful approach for solving engineering problems, [4, 2, 6], but this approach has yet to be
implemented for tting kinetic models. Building a rigorous framework for kinetic model
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parameter identication can lead to a better parameter estimation in the large scale kinetic
models. Furthermore, kinetic models are built on specic physical laws. Therefore, nd-
ing a surrogate model based on these physical laws can guide the optimization algorithm
in the correct direction to nd unique global minima of objective function. Such, func-
tional surrogate model will improve the parameter identication signicantly. Following
this procedure will ensure better prediction by the large kinetic models and will increase






A.1 Kinetic Mechanism Details
A.1.1 Abbreviation
Subscript c and m on state variables or on ux expression denotes cytoplasmic and mito-
chondrial compartments respectively.
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Table A.1: Abbreviations for metabolites/Enzymes




FBA fructose-bisphosphate aldolase E.C.4.1.2.13
GAPD glyceraldehyde 3-phosphate dehydrogenase E.C.1.2.1.12
PGP bisphosphoglycerate phosphatase E.C.5.4.2.1/E.C.5.4.2.4
PK Pyruvate kinase E.C.2.7.1.40




CS Citrate Synthase EC4.1.3.7
FM Fumarase EC4.2.1.2
IDHm Isocitrate Dehydrogenase Mitochondrial EC1.1.1.41
IDHc Isocitrate Dehydrogenase (NADP+) Cytoso-
lic
EC1.1.1.42
MDH Malate Dehydrogenase EC1.1.1.37
OGC Oxoglutarate Carrier
PC Pyruvate Carboxylase EC6.4.1.1
PDC Pyruvate Dehydrogenase Complex EC1.2.4.1
PYC Pyruvate Carrier
AKD α-Ketoglutarate Dehydrogenase EC1.2.4.2 etc.
SCS Succinyl-CoA synthetase EC6.2.1.4
SDH Succinate Dehydrogenase EC1.3.5.1
MEm Malic Enzyme Mitochondrial EC1.1.1.39





Table A.2: Abbreviations for metabolites/Enzymes




GAP_c Glyceraldehyde 3-phosphate C00118
DPG_c 1,3-bisphospho-D-glycerate C00236








NADPH_c Nicotinamide Adenine Dinucleotide Phos-
phate
C00005













CO2 Carbon Dioxide C00011
ATP Adenosine Triphosphate C00002
ADP Adenosine Diphosphate C00008
NAD+ Nicotinamide Adenine Dinucleotides (Oxi-
dized)
C00003
NADH Nicotinamide Adenine Dinucleotides C00004
CoA Coenzyme A C00010
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A.1.2 Model Reactions
Table A.3: Model Reactions
Flux Enzyme Reaction
J0entry_s GT InputGlucose 
 GLC_c
J1gk_c GK GLC_c + ATP→ F6P_c + ADP
J2pfk_c PFK F6P + ATP→ FBP + ADP
J3fba_c FBA FBP
 2GAP
J4gapd_c GAPD GAP + NAD→ DPG + NADH
J5pgp_c PGP DPG + ADP
 PEP + ATP
J6pk_c PK PEP + ADP→ PYR + ATP
J9pyr_s PYC PYR_c + H_m
 PYR_m + H_c
J10cit_s CIC CIT_c + MAL_m
 CIT_m + MAL_c
J11icit_s CIC ICIT_c + MAL_m
 ICIT_m + MAL_c
J12akg_s OGC AKG_c + MAL_m
 AKG_m + MAL_c
J13malh_s DIC MAL_c + Pi_m




J15citl_c CITL CIT_c→ OXA_c
J16mdh_c MDH MAL_c + NAD
 OXA_c + NADH
J17acon_c ACO CIT_c
 ICIT_c
J18isod_c IDHb ICIT_c + NADP
 AKG_c + NADPH
J19me_c MEb MAL_c + NADP
 PYR_c + NADPH
J20pdh_m PDC PYR_m + NAD + CoA→ ACO_m + NADH + CO2
J21pc_m PC PYR_m + ATP_m + CO2 
 OXA + ADP + Pi
J22cs_m CS OXA_m + ACOA_m→ CIT_m + CoA
J23ac_m ACO CIT_m
 ICIT_m
J24icd_m IDHa ICIT_m + NAD→ AKG_m + NADH
J25akg_m OGDC AKG_m + NAD + CoA→ SCOA_m + NADH + CO2
J26sco_m SCS SCOA_m + GDP + Pi
 SUC_m + CoA + GTP
J27sdh_m SDH SUC_m + Q
 FUM_m + QH2
J28fum_m FM FUM_m
 MAL_m
J29mdh_m MDH MAL_m + NAD
 OXA_m + NADH
J30me_m MEa MAL_m + NAD
 PYR_m + NADH
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A.1.3 Species which are held at constant concentration
Table A.4: Species concentration which are held at constant value and constant Parameters
Species Constant value
COA_m 3.0 × 10−3 M [114]
Qm 9.5 × 10−4 M [114]
QH2_m 4.1 × 10−4 M [114]
CO2 3.0 × 10−6 M [114]
pH 8.0 [88]
NAD_m 2.0 × 10−4 M [110]
NADH_m 1.0 × 10−4 M [110]
NAD_c 5.0 × 10−5 M [34]
NADH_c 2.0 × 10−7 M [34]
ATP_c 5.0 × 10−3 M [114]
ADP_c 5.0 × 10−5 M [108]
Pi_c 1.0 × 10−3 M [108]
ATP_m 1.0 × 10−2 M [114]
ADP_m 5.0 × 10−3 M [114]
Pi_m 1.010−3 M [114]
inglc Input Glucose varies from 2.5mM to 22mM
Vr 20.0 [110]
NADPtot 5.0 × 10−4 M [88]
A.1.4 Rate Expressions
Kinetic Expression Simplication The model is divided into two sub parts: (i) the
glycolysis model, and (ii) TCA cycle model, including pyruvate recycling. The glycolysis
model is treated as inux model for pyruvate recycling and is not included in the model
analysis. The glycolysis model is built as six step pathway generating pyruvate as described
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earlier in Jiang et.al. [47]. The kinetic mechanism and parameters are taken from SABIO-
RK [112] Details are provided in Table A.5.
The TCA cycle model and pyruvate recycle enzyme kinetics (Tables A.6, A.7 and
A.8) are adapted from Yugi and Tomita [116] and Westermark et.al. [110], with the
exceptions of lactate dehydrogenase (adapted from Hoefnagel et.al. [40]), malic enzyme
(mitochondrial and cytosolic), and pyruvate dehydrogenase for both of which we developed
our own kinetics. Parameters for these kinetics were taken from Brenda database [96].
Furthermore, we rened the cytosolic isocitrate dehydrogenase kinetics by removing CO2
from the kinetics and taking new parameters from the Brenda database [96].
Since the goal of the model was to understand the role of pyruvate recycling we held
the concentrations of ions and some metabolites constant, thus simplifying some kinetic
expressions. As an example of this procedure, consider the pyruvate transport rate expres-
sion of Yugi and Tomita [116]. The original model includes transport of hydrogen (as an
antiporter); in our model the hydrogen concentration in both compartments is held xed,
so we reduced the expression by combining the constant concentration with the kinetic



















Since [H_c] and [H_m] are constant we can combine the concentration values with kinetic
parameters to give
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[H_m] · v9_mf = v9_1
[H_c] · v9_mr = v9_2





are constant terms say this terms are temp0 and temp1 respectively.
Now we have terms like this [PYR_c]·[H_m]
v9_KiA·v9_KiQ in which the hydrogen concentration has been
xed. These can be combined to give
[H_m]
v9_KiA·v9_KiQ = temp2





+ [PYR_c] · temp2 + [PYR_m] · temp3 + temp0 + temp1 + 1
Combining all the pyruvate terms and factoring out the constant term from the denomi-
nator we have the reduced expression
v9_1·[PYR_m]−v9_2·[PYR_c]
1+v9_3·[PYR_m]+v9_4·[PYR_c]
Similar reductions were carried out for the other rate expressions.
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Table A.5: Glycolysis kinetics. Glycolysis is modeled as a six-step reaction pathway gener-
ating pyruvate. These reactions are treated as inux to the pyruvate recycling pathways.
Reaction Flux expression Reference
J0entry_s v0_1·(inglc−[GLC_c])





























SABIO Reaction ID 10478.
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Table A.6: Transporter rates. All the kinetics are described by Rapid Equilibrium
Random Bi Bi kinetics
Reaction Flux expression Reference
J9pyr_s v9_1·[PYR_m]−v9_2·[PYR_c]
1+v9_3·[PYR_m]+v9_4·[PYR_c] Yugi and Tomita [116]
J10cit_s [CIT_c]·[MAL_m]·v10_1−[MAL_c]·[CIT_m]·v10_2
denom

















Yugi and Tomita [116]
J11icit_s [ICIT_c]·[MAL_m]·v11_1−[MAL_c]·[ICIT_m]·v10_2
denom

















Yugi and Tomita [116]
J12akg_s [AKG_m]·[MAL_c]·v12_1−[MAL_m]·[AKG_c]·v12_2
denom

















Yugi and Tomita [116]
J13malh_s v13_1·[MAL_m]−v13_2·[MAL_c]
1+v13_3·[MAL_m]+v13_4·[MAL_c] Yugi and Tomita [116]
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Table A.7: Cytosolic Fluxes
Reaction Flux expression Reference
J7ldh_c
v7_1·([PYRc_m]− [LAC_c]v7_eq )










1+v15_3·[CIT_c]+v15_4·[OAA_c] Westermark et.al. [110]
J16mdh_c v16_1·([MAL_c]−v16_2·[OAA_c])
1+v16_3·[MAL_c]+v16_4·[OAA_c] Yugi and Tomita [116]
J17acon_c v17_1·[CIT_c]−v17_2·[ICIT_c]



































Bi Bi. All parameters
from Brenda[96].
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Table A.8: Mitochondrial Fluxes










product inhibition. All the
parameters from Brenda[96]
J21pc_m v21_1·(v21_2·[PYR_m]−[OAA_m])
1+v21_3·[PYR_m]+v21_4·[OAA_m] Yugi and Tomita [116]
J22cs_m v22_1·[ACO_m]·[OAAm_m]
[ACO_m]·[OAA_m]+v22_2·[OAA_m]+v22_3·[ACO_m]+1 Yugi and Tomita [116]
J23ac_m v23_1·[CIT_m]−v23_2·[ICIT_m]
v23_3·[ICIT_m]+v23_4·[CIT_m]+1 Yugi and Tomita [116]
J24icd_m
v24_1·([ICIT_m]2+v24_2·[ICIT_m])
v24_3[ICIT_m]2+v24_4·[ICIT_m]+1 Yugi and Tomita [116]
J25akg_m v25_1·[AKG_m]
1+v25_2·[AKG_m]+V25_3·[SCOA_m]+v25_4·[AKG_m][SCOA_m] Yugi and Tomita [116]
J26sco_m v26_1·(v26_2·[SCOA_m]−[SUC_m])(v26_3·[SUC_m]+1)
denom
denom = 1+v26_4 · [SCOA_m] + v26_5 · [SUC_m]+
v26_6 · [SUC_m]2 + v26_7 · [SCOA_m][SUC_m]
Yugi and Tomita [116]
J27sdh_m v27_1·([SUC_m]−[FUM_m]·v27_2)
1+v27_3·[SUC_m]+v27_4·[FUM_m]+V27_5·[SUC_m][FUM_m] Yugi and Tomita [116]
J28fum_m v28_1·[FUM_m]−v28_2·[MAL_m]
v28_3·[MAL_m]+v28_4·[FUM_m]+1 Yugi and Tomita [116]
J29mdh_m v29_1·[MAL_m]−v29_2·[OAA_m]




1+v30_2·[MAL_m]+v30_3·[PYR_m] Modeled as Reversible
Michaelis Menten. All the
parameters from Brenda[96]
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= J6pk_c− J7ldh_c+ V r ∗ J9pyr_s+ J19me_c
d[MAL_c]
dt




= −J17acon_c− J15citl_c− V r ∗ J10cit_s
d[ICIT_c]
dt
= −J18isod_c+ J17acon_c− V r ∗ J11icit_s
d[AKG_c]
dt






= J18isod_c+ J19me_c− J14nadph_c
d[PY R_m]
dt






= J22cs_m− J23ac_m+ J10cit_s
d[ICIT_m]
dt
= J23ac_m− J24icd_m+ J11icit_s
d[AKG_m]
dt













= −J29mdh_m+ J28fum_m− J10cit_s
− J11icit_s− J13malh_s+ J12akhmal_s− J30me_m
d[OAA_m]
dt
= −J22cs_m+ J29mdh_m+ J21pc_m
A.1.6 ODE Initial Conditions
The initial condition is xed by integrating the system from 0 initial condition till 4hrs
(7200s) under appropriate glucose conditions.
A.2 Computational Settings for Solvers
A.2.1 Steady State Calculation
To calculate the steady state we used the ode15s and fsolve functions of MATLAB®. The
dierential equation was rst integrated up to 107 seconds. This point was then passed to
fsolve to conrm the steady state conditions had been achieved,. In order to increase stabil-
ity and robustness of solvers, we generated symbolic Jacobians using SBTOOLBOX2 [97].
Since only 18% of the Jacobian coecients were non-zero, we utilized the sparse storage
mechanism as described in the ode15s and fsolve manual in order to increase the eciency
of solvers. We xed the relative tolerance of ode15s at 1e-3 and the absolute tolerance at
1e-6 except for F6P and G6P which were xed at 1e-12. For fsolve we choose the default
values of TolX and TolF (1e-6).
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A.2.2 Parameter Optimization
Parameter optimization proceeded in two steps. To begin, we tted the glycolysis pa-
rameters to appropriate levels of the output pyruvate. In the second phase of parameter
estimation some of the parameters were manually adjusted and then second subset of pa-









where N is the number of experimental time-points, xobs(x)i is the observed value of i
th
state, xsim(x)i is the corresponding i
th simulated state and σi is the standard error of
mean (SEM) of the ith state. If the error is unknown then it was assumed to be 10%.
The parameters were optimized in the range .01pnom ≤ pnom ≤ 100pnom, where pnom is
the nominal parameter values.We used a combination of simplexSB and simannealSB of
system biology toolbox for parameter optimization [97].
A.2.3 Global Sensitivity Analysis Settings
We used the variance-based Global Sensitivity Analysis (GSA) Sobol's Method, extended
Fourier amplitude sensitivity test (eFAST) and partial rank correlation method (PRCC)
implemented in SBTOOLBOX2 [97]. The analysis treated all model parameters expect
for the glycolysis parameters. The relative parameter range variation was selected to be
100%. For the total sensitivity analysis, the objective function was dened as the sum of
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where xnom is the steady state nominal model output and xpert is the steady state perturbed
model output,n is the number of varaibles. In addition we calculated the sensitivities of
individual variables. This can simply be dened as a squared error of each variable without
any extra model evaluation.
f iind = (x
i
nom − xipert)2 for i=1..n
The Total number of model simulations was selected to be 105, based on the suggestion of
Saltelli [93] (N = 2 ∗ 512 ∗ total number of parameters).
The system output was taken as all the state variables and uxes participating in
TCA cycle and pyruvate recycling pathways (none from the glycolysis pathway). Similarly,
parameters was choosen excluding glycolysis. The total numbers of parameters for analysis
was 100.
Integration Settings for Global Optimization For simulating the model for global
sensitivity analysis we used the SUNDIALS [39] package (MATLAB® interface) in order to
reduce the simulation time [97]. The nal value was checked for steady-state as described
previously using fsolve. The function was integrated using a relative tolerance of 1e-4 and
an absolute tolerance of 1e-14 for all the species. With this setting the integrator output
is the same as MATLAB® ode15s solver.
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A.3 Parameters
Parameter Classication We classied the parameters as follows
Table A.9: Classication of dierent parameters
Class Denition Example
Class 0 Literature values v1_3
Class 1 Optimized around the experimen-
tal values or estimated to t the
training data
v0_1 or ? ≤ v14_1 ≤?
Table A.10: Model parameters. This model contains 123 global parameters. Units: Mo-
larity (M) Seconds (s)
Name Value Units Class Name Value Units Class
v0_1 2.7271 · 10−6 M·s−1 1 v6_3 2.9 0
v0_2 101.0544 M 1 v7_1 29.0969 M·s−1 1
v1_1 1.3424 · 10−4 M·s−1 1 v7_eq 21.121 0
v1_2 3.0118 · 10−4 M 1 v7_2 448491.0 M 1
v1_3 1.34 0 v7_3 449.0936 M 0
v2_1 3.16667 · 10−5 M·s−1 0 v9_1 3.7674 · 10−8 M·s−1 1
v2_2 0.0089 M 0 v9_2 0.004 M·s−1 1
v2_3 0.9 0 v9_3 49.2637 M 1
v3_1 7.97833 · 10−5 M·s−1 0 v9_4 187.3789 M 1
v3_2 4 · 10−6 M 0 v10_1 32514.0 M·s−1 0
v4_1 0.001 M·s−1 0 v10_2 84267.0 M·s−1 0
v4_2 3.2 · 10−4 M 0 v10_3 1.3 · 10−4 M 0
v4_3 1.5 0 v10_4 4.4 · 10−4 M 0
v5_1 3.33 · 10−5 M·s−1 0 v10_5 3.3 · 10−4 M 0
v5_2 8 · 10−6 M 0 v10_6 4.18 · 10−5 M 0
v6_1 5.33 · 10−5 M·s−1 0 v12_1 5811.9 M·s−1 0
v6_2 1.5 · 10−4 M 0 v12_2 6739.9 M·s−1 0
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Table A.11: Model parameters. This model contains 123 global parameters. Units: Mo-
larity (M) Seconds (s)
Name Value Units Class Name Value Units Class
v12_3 3 · 10−4 M 0 v20_1 1.417 · 10−7 M·s−1 0
v12_4 7 · 10−4 M 0 v20_2 3.5 · 10−5 M 0
v12_5 .0014 M 0 v20_3 2 · 10−5 M 0
v12_6 1.7 · 10−4 M 1 v21_1 0.1057 M·s−1 1
v13_1 0.8512 M·s−1 0 v21_2 0.54 M 1
v13_2 0.2721 M·s−1 0 v21_3 4424100.0 M 1
v13_3 1388.9 M 0 v21_4 4.8528 · 107 M 1
v13_4 1111.1 M 0 v22_1 50.85 M·s−1 1
v14_1 0.0025598 M·s−1 1 v22_2 2.5 · 1010 M 1
v14_2 0.98653 M 0 v22_3 295000.0 M 0
v15_1 4.0008 · 10−7 M·s−1 1 v22_4 120000.0 M 1
v15_2 1.2 · 10−4 M 1 v23_1 0.0518 M·s−1 0
v16_1 .0036 M·s−1 0 v23_2 0.1104 M·s−1 0
v16_2 5000 M·s−1 0 v23_3 9090.9 M 0
v16_3 8 · 10−6 M 0 v23_4 2000.0 M 0
v16_4 16667 M 0 v24_1 0.1126 M·s−1 0
v17_1 0.0518 M·s−1 0 v24_2 0.0148 M·s−1 0
v17_2 0.1104 M·s−1 0 v24_3 2777.5 M 0
v17_3 9090.0 M 0 v24_4 0.63969 M 0
v17_4 2000.0 M 0 v25_1 0.0311 M·s−1 1
v18_1 1152100.0 M·s−1 0 v25_2 1.456 · 109 M 1
v18_2 5482500.0 M·s−1 0 v25_3 1.4546 · 109 M 1
v18_3 2.3042 · 1010 M 0 v25_4 24691.0 M 1
v18_4 142857.1 M 0 v26_1 3.32 · 10−5 M·s−1 1
v18_5 161290.3 M 0 v26_2 6.4 M 1
v18_6 1.0965 · 1011 M 0 v26_3 4.1876 M 1
v18_7 416666.7 M 0 v26_4 37.5348 M 1
v18_8 263157.9 M 0 v26_5 1478.2 M 1
v19_1 913070.0 M·s−1 0 v26_6 9509.6 M 1
v19_eq 1000 0 v26_7 236.7114 M 1
v19_2 1.2 · 10−4 M 0 v27_1 2.941 M·s−1 1
v19_3 1.39 · 10−6 M 0 v27_2 11.5344 M 1
v19_4 0.0048 M 0 v27_3 449.6613 M 1
v19_5 5.3 · 10−6 M 0 v27_4 199130.0 M 1
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Table A.12: Model parameters. This model contains 123 global parameters. Units: Mo-
larity (M) Seconds (s)
Name Value Units Class
v27_5 1.7921 · 108 M 1
v28_1 13.9024 M·s−1 1
v28_2 13.9024 M·s−1 1
v28_3 4000000.0 M 1
v28_4 880000.0 M 1
v29_1 .0016 M·s−1 1
v29_2 2.5563 · 10−10 M·s−1 1
v29_3 33263.0 M 1
v29_4 14.0754 M 1
v29_5 2742900.0 M 1
v30_1 157.8125 M·s−1 1
v30_eq 1000 1
v30_2 500 M 1
v30_3 227.2727 M 0
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A.4 Supplementary Sensitivity Plots
A.4.1 Sensitivity Rankings: Overall Measures






















OVERALL MEASURE Global Sensitivity
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OVERALL MEASURE Global Sensitivity
(d)
Figure A.1: Global Sensitivity Rankings of Overall Measures across dierent methods.
Panel A eFAST total eect, Panel B eFAST rst order, Panel C Sobol's total eect and
Panel D PRCC. For parameters description refer to Tables A.8,A.7 and A.6
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A.4.2 ICDc eect
We perturbed the Vmax of ICDc and measured the eect on the pyruvate recycle uxes.
As expected the transport uxes are more eected and there is no signicant eect on PC
and MEc or MEm. The result is shown in gure A.2.
























v18_1 Vmax forward ISODc
(a)



























v18_2 Vmax reverse ISODc
(b)
Figure A.2: A.2a Eect of perturbation in Vmax forward on uxes. A.2b Eect of pertur-
bation in Vmax reverse on uxes.
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Figure A.3: Global Sensitivity Rankings of ICDc across dierent methods. Panel A eFAST
total eect, Panel B eFAST rst order, Panel C Sobol's total eect and Panel D PRCC.
For parameters description refer to Tables A.8,A.7 and A.6
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A.4.3 Mitochondrial Pyruvate Sensitivity















































































































Figure A.4: Global Sensitivity Rankings of mitochondrial pyruvate across dierent meth-
ods. Panel A eFAST total eect, Panel B eFAST rst order, Panel C Sobol's total eect
and Panel D PRCC. For parameters description refer to Tables A.8,A.7 and A.6
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